<rss version='2.0'>

                    <channel>

                    <title><![CDATA[Dementia]]></title>

                    <link>https://www.benthamscience.com</link>

                    <description>

                    RSS Feed for Disease Wise Article | BenthamScience

                    </description>

                    <generator>EurekaSelect (+http://eurekaselect.com)</generator>

                    <pubDate>Tue, 19 May 2026 21:31:24 +0000</pubDate>

                    <image>

                    <title><![CDATA[Dementia]]></title>

                    <url>https://www.benthamscience.com</url>

                    <link>https://www.benthamscience.com</link>

                    </image><item><title><![CDATA[<i>In Silico</i> Tools to Leverage Rational Drug Design and Development in LMICs]]></title><link>https://www.benthamscience.comchapter/23780</link><description><![CDATA[Drug discovery and development is a time-consuming, complex, and expensive process. Usually, it takes about 15 years in the best scenario since drug candidates have a high attrition rate. Therefore, drug development projects rarely take place in low and middle-income countries (LMICs). Traditionally, this process consists of four sequential stages: (1) target identification and early drug discovery, (2) preclinical studies, (3) clinical development, and (4) review, approval and monitoring by regulatory agencies.<br><br>During the last decades, computational tools have offered interesting opportunities for Research and Development (R &amp; D) in LMICs, since these techniques are affordable, reduce wet lab experiments in the first steps of the drug discovery process, reduce animal testing by aiding experiment design, and also provide key knowledge involving clinical data management as well as statistical analysis. <br><br>This book chapter aims to highlight different computational tools to enable early drug discovery and preclinical studies in LMICs for different pathologies, including cancer. Several strategies for drug target selection are discussed: identification, prioritization and validation of therapeutic targets; particularly focusing on high-throughput analysis of different “omics” approaches using publicly available data sets. Next, strategies to identify and optimize novel drug candidates as well as computational tools for costeffective drug repurposing are presented. In this stage, chemoinformatics is a key emerging technology. It is important to note that additional computational methods can be used to predict possible uses of identified human-aimed drugs for veterinary purposes. Application of computational tools is also possible for predicting pharmacokinetics and pharmacodynamics as well as drug-drug interactions. Drug safety is a key issue and it has a profound impact on drug discovery success. Finally, artificial intelligence (AI) has also served as a potential tool for drug design and discovery, expected to be a revolution for drug development in several diseases.<br><br>It is important to note that the development of drug discovery projects is feasible in LMICs and in silico tools are expected to potentiate novel therapeutic strategies in different diseases.<br><br>This book chapter aims to highlight different computational tools to enable early drug discovery and preclinical studies in LMICs for different pathologies, including cancer. Several strategies for drug target selection are discussed: identification, prioritization and validation of therapeutic targets; particularly focusing on high-throughput analysis of different “omics” approaches using publicly available data sets. Next, strategies to identify and optimize novel drug candidates as well as computational tools for costeffective drug repurposing are presented. In this stage, chemoinformatics is a key emerging technology. It is important to note that additional computational methods can be used to predict possible uses of identified human-aimed drugs for veterinary purposes.<br><br>Application of computational tools is also possible for predicting pharmacokinetics and pharmacodynamics as well as drug-drug interactions. Drug safety is a key issue and it has a profound impact on drug discovery success. <br><br>Finally, artificial intelligence (AI) has also served as a potential tool for drug design and discovery, expected to be a revolution for drug development in several diseases.Application of computational tools is also possible for predicting pharmacokinetics and pharmacodynamics as well as drug-drug interactions. Drug safety is a key issue and it has a profound impact on drug discovery success. Finally, artificial intelligence (AI) has also served as a potential tool for drug design and discovery, expected to be a revolution for drug development in several diseases.<br><br>&nbsp;]]></description> </item><item><title><![CDATA[List of Contributors]]></title><link>https://www.benthamscience.comchapter/23779</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Molecular Mechanisms Implicated with Depression and Therapeutic Intervention]]></title><link>https://www.benthamscience.comchapter/22447</link><description><![CDATA[Depression is a pervasive, arduous psychological condition with profound neurological ramifications. The parameters for leveraging depression involve the diagnosis and evaluation of depression, the endorsement to implement substantiated therapies and rigorous follow-up of the patients. Many individuals suffering from depression undertake a recurring or persistent therapy that correlates to a decline in cognitive processing. The underpinnings of exact aetiology and pathogenesis of melancholy are probably the outcome of a variety of mechanisms. These include physiological, behavioural, and socio-economic variables, all playing their roles. Multiple refinements to the treatments encompassing therapies, medications and medical interventions are employed, in relation to effective approaches reassuring the brighter side. In this chapter, we discuss more integrative and multifaceted aspects of psychological health, minimizing the segmented understanding to achieve a consensus on multiple possibilities for effective interventions.<br>]]></description> </item><item><title><![CDATA[Client-Centered, Person-Centered, and Resilience-Based Approaches to Trauma-Informed Care]]></title><link>https://www.benthamscience.comchapter/22231</link><description><![CDATA[Chapter three explores client-centered, person-centered, and resiliencefocussed approaches to trauma-informed care, and although they differ somewhat, all three are strength-based and share the common goal of helping people who have experienced adversity. Client-centered care places the person and their capacity for growth and change at the heart of all that occurs. This approach prioritizes respect for the self-worth of every human being and promotes the practice of unconditional positive regard. The quality of the therapeutic relationship between the nurse and client/patient is important, as is the nurse’s ability to apply professional knowledge and competence to the care they provide. A unique aspect of person-centered care is that it provides services to people with acute and chronic health issues that are holistic, and recovery-orientated. Collaboration and effective communication skills are essential features of this approach. Positive ways to offer person-centered care to people from these populations are reviewed, the elderly, those with a disability, people with dementia, palliative care patients, and persons suffering from mental illness and substance use. Specific components of recovery-oriented care that are included in the discussion are a person’s capacity for change and courage, their responsibility for their growth, and the importance of finding purpose in their lives. Resilience is identified as the is the ability to carry on and bounce back to original functioning after experiencing a trauma. We are made aware that a resilient person becomes stronger despite adversity because they utilize positive emotions, develop a sturdy mindset, a renewed commitment to life, and welcome challenges. The remainder of the discussion focuses on how to safely conduct screening for trauma for everyone including survivors of interpersonal violence (IPV). Two Narrative Case Studies are presented. The first one demonstrates that when a client/patient crosses a professional boundary, a problem is created for the nurse. The second Case Study explores how a survivor of interpersonal violence (IPV) may require advocacy to help them stay safe. The following four learning activities are recommended, how to practice unconditional positive regard; exploring helpful strategies to utilize when conducting trauma screening; dispelling myths associated with IPV; and how to implement survivor-centered approaches when caring for someone who has experienced IPV. At the end of the Chapter, a self-care strategy is recommended that challenges nurses to set aside time to focus more on being present.<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/22215</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Common Surgical Procedures in Geriatric Patients]]></title><link>https://www.benthamscience.comchapter/22214</link><description><![CDATA[Demographic studies show that life expectancy for people in the USA has been trending upwards for the past several decades. As the population ages, the number of geriatric patients who will require surgery has also increased. Information from the National Hospital Discharge Survey reported that in 2006, 35.3% of all inpatient procedures and 32.2% of all outpatient procedures were in patients aged 65 and older. Common elective surgeries in elderly patients include cataract and lens procedures, spinal fusions and laminectomies, and total or partial hip and knee replacements. Common urgent surgeries in this population include thoracic and abdominal cancer resections, breast and prostate cancer resections, and cholecystectomies. Finally, common emergency surgeries in the elderly population include hip fracture repairs and other geriatric traumas.&nbsp;<br>]]></description> </item><item><title><![CDATA[The Geriatric COVID Patient]]></title><link>https://www.benthamscience.comchapter/22213</link><description><![CDATA[The COVID-19 pandemic resulted in a significant impact on healthcare across the world. The pandemic is caused by the coronavirus SARS-CoV-2 and is transmitted through respiratory secretions. The geriatric population comprised most morbidities and mortalities related to COVID-19. Common symptoms include fever, cough, dyspnea, myalgia, and culminating in acute hypoxic respiratory failure and acute myocardial injury. Geriatric patients with COVID-19 who require surgery are at a greater risk of postoperative complications. An assessment of the risks and benefits of surgical intervention relies on the degree of COVID-19 pathology and the type of surgery whether emergent or elective. The presence of COVID-19 does not warrant a change in the modality of anesthesia that would be performed for any given surgery in the absence of COVID-19.<br>]]></description> </item><item><title><![CDATA[Female Geriatric Patients]]></title><link>https://www.benthamscience.comchapter/22212</link><description><![CDATA[Men and women are created equal, but there are some biological differences between the two sexes that should be considered in the perioperative period to provide safe and equitable care. This chapter highlights specific anatomical differences between men and women and discusses conditions by system that are more prevalent among female geriatric patients. Plus, it briefly discusses particular sex differences in the pharmacokinetics of some drugs.<br>]]></description> </item><item><title><![CDATA[Ethics and Legal Issues in Geriatric Anesthesia]]></title><link>https://www.benthamscience.comchapter/22211</link><description><![CDATA[This chapter discusses the ethical and legal challenges faced by anesthesiologists in geriatric anesthesia due to medical, economic, and social issues. Anesthesiologists must exhibit patience, understanding, and compassion in order to overcome multiple challenges. It is also imperative that they stay up-to-date on the issues facing this particular population in order to adequately address them efficiently through collaborative communication and active involvement in patient care.<br>]]></description> </item><item><title><![CDATA[Anesthetic Considerations for Patients with Chronic Neurologic Disorders]]></title><link>https://www.benthamscience.comchapter/22209</link><description><![CDATA[Chronic neurological disorders encompass a broad range of challenges for the surgical and anesthesiology team in the perioperative setting. According to the World Population Prospects 2019, by 2050, 1 in 6 people will be over 65, from 1 in 11 in 2019 [1]. As our population continues to age, our understanding and ability to provide medical and surgical services must improve as well. Perioperative strokes are rare, but they can greatly impact a patient's recovery and function when they occur. Dementia strongly predicts postoperative complications, higher hospital costs, and 30- day mortality [2]. Patients with Parkinson’s disease are at a higher risk of perioperative medical and surgical complications not to mention specific medication regimens that need to be adjusted to avoid worsening symptomatology. Although rare, a patient presenting with Amyotrophic lateral sclerosis (ALS), can present with a broad range of neurologic symptoms, and cardiovascular and pulmonary dysfunction that can be daunting for any anesthesia provider. In this chapter, we will explore the comprehensive approach to managing chronic neurologic disorders, including multidisciplinary care, early identification of potential complications, specialized medication management, and intraoperative considerations.<br>]]></description> </item><item><title><![CDATA[Geriatric Pain Patient]]></title><link>https://www.benthamscience.comchapter/22205</link><description><![CDATA[Chronic pain is a major cause of physical disability, poor mental health, and decreased quality of life [1,2]. The burden of chronic pain is reflected in increased medical care utilization and consequently increased healthcare costs, which are estimated at an astounding $560 billion per year [3]. CDC estimates from 2019 reveal that while 20.4% of adults in the USA live with chronic pain, the prevalence increases with advancing age [4]. 30.8% of people aged 65 years and above had chronic pain while 11.8% of them had high-impact chronic pain, which is defined as pain that causes significant restriction of self-care, social and work-related activities [5]. The impact of chronic pain is more severe in the elderly; older adults report poorer physical health and disability in comparison to younger adults [6-8]. Chronic pain in the elderly is also associated with poorer sleep, cognitive decline, dementia, and death [9-13]. With the projected increase in the elderly population in the US every year, the burden of chronic pain is only expected to increase. This chapter outlines the physiologic and pharmacologic changes that happen with ageing, the major causes of chronic pain in the elderly, as well as the myriad of treatment options available with a focus on pharmacotherapy, behavioral and alternative therapies, and interventional pain therapies. The focus of treatment is not only targeted towards reducing pain but special considerations should be made to minimize the cognitive effects of polypharmacy in light of multiple comorbidities and promote mental well-being and functional independence [14].<br>]]></description> </item><item><title><![CDATA[Postoperative Cognitive Dysfunction (POCD) in Geriatric Patients]]></title><link>https://www.benthamscience.comchapter/22200</link><description><![CDATA[As the world population ages, the number of older patients undergoing surgery will increase significantly. Postoperative cognitive dysfunction (POCD) and other perioperative neurocognitive disorders (PND) affecting patients after surgery have long been recognized in older patients and are considered some of the most common postoperative complications. POCD has been correlated with significant morbidity and mortality, and greater healthcare costs. Historically, the lack of standardized nomenclature used to describe cognitive change after surgery and anesthesia has made it challenging to conduct systematic reviews or analyze the results of similar studies to further understand the clinical implications of this disorder. This has led to minimal recognition of this disorder outside of the specialty of anesthesiology. Patient and surgery-related risk factors include old age, preexisting cognitive changes, and emergency surgery amongst others. Proposed etiologies include postsurgical neuroinflammation, impairment of neurotransmitter systems, and cerebral vascular events in the perioperative period. The medical literature offers little guidance to recommend a particular anesthetic to decrease the risk of POCD in the postoperative patient. Most studies found similar risks of POCD after general and regional anesthesia techniques. While there is no standardized test for diagnosing preoperative cognitive impairment, it is critical to identify high-risk patients so that timely interventions can be made to minimize POCD.<br>]]></description> </item><item><title><![CDATA[Pre-Operative Evaluation and Optimization of Geriatric Patient]]></title><link>https://www.benthamscience.comchapter/22198</link><description><![CDATA[Worldwide, life expectancy is increasing and people are living longer. Between 2015 and 2050, the proportion of the world’s population over the age of 60 years is expected to double from 12% to 22% [1]. As our elderly population grows, more elderly patients now require elective, urgent, and emergent surgery. Elderly patients are complex due to age-related changes and comorbidities. Anesthesia provides a critical line of defense for these patients, and this begins with a comprehensive pre-operative evaluation. Assessment begins with a history and physical exam and is supplemented with laboratory and clinical data. Special attention must be given to nutritional status, functional capacity, cardiovascular and pulmonary function, cognitive function, and emotional well-being. Understanding the physiologic changes of aging and common pathologies in the elderly helps predict the pharmacokinetics and pharmacodynamics of anesthetic agents. This understanding also helps plan for the hemodynamic, ventilatory, and cognitive impacts of anesthesia on the elderly. Perhaps equally important to determine a patient’s physical condition is establishing the individual’s goals of care, decision-making capacity, and surrogate decision-making for anesthesia and surgery.]]></description> </item><item><title><![CDATA[Genome Editing Against Bacterial Plant Pathogens]]></title><link>https://www.benthamscience.comchapter/22110</link><description><![CDATA[Meeting the crucial demand for sustainable agriculture is an upcoming challenge worldwide, leading to global food security concerns. Approximately 50% of agricultural loss is caused by both biotic and abiotic stresses. As per the estimation of Agrios, 42% of crop loss is characterized by biotic stress alone. Bacteria are the second largest contributor in terms of economic losses caused by various plant diseases. Hence, there is a need to develop elite cultivars in amalgamation with readily available sequenced plant database and progressive genome editing. This has proved to be a groundbreaking/milestone in the field of plant breeding for any desired trait. Until now, many new plant breeding techniques (NPBTs) have been introduced for crop improvement. These techniques include site-specific mutagenesis, cisgenesis, intragenesis, breeding with transgenic inducer lines, etc. This book chapter provides a comparative understanding of enrichment in plant genome editing approach about bacterial pathogens aiming for sustainable agriculture development. This chapter also brings a broad aspect of the application, advantages, unsighted aspects of genome editing, and future challenges.<br>]]></description> </item><item><title><![CDATA[Future Perspective of Aromatherapy in Skin and Cancer Therapeutics]]></title><link>https://www.benthamscience.comchapter/22105</link><description><![CDATA[Essential oils have a direct influence on cancer cells along with an impact at a chemical level on the immune system. Essential oils work efficiently in getting rid of microorganisms and other foreign bodies from the human body by augmenting white blood cell activity. Many more small molecules change the way that the main components of many essential oils act. Furthermore, numerous components play an important part in various characteristics of essential oils like smell/fragrance, concentration, colour, texture, cell diffusion, lipophilicity/hydrophilicity, and fixation over cellular membranes and their distribution within the cell. Biologically, in the central nervous system disorders, volatile essential oils may affect synergistically along with the treatment drugs/chemicals. One of the important considerations is the specific time at which the plant possesses the highest quantity of volatile essential oils along with the chemical constituent mixture. Essential oils are a beneficial non-medicinal alternative and they could be included in routine conventional care for some particular health conditions when their protection and quality control issues have been calculated. Alternative medicine involving the usage of essential oils is hopeful to decrease the redundant effects of current medicine and if explored precisely, the therapy will benefit both the patients and the common man.<br>]]></description> </item><item><title><![CDATA[Essential Oils’ Biosynthesis and their Application]]></title><link>https://www.benthamscience.comchapter/22101</link><description><![CDATA[Essential oils are natural plant products that have a wide range of applications in various fields like medicine, flavors, fragrance, etc. Their wide range of uses benefits people by exhibiting a variety of diverse properties like anti-allergic, antiinflammatory, antiviral, antibacterial, insect repellent, anticancer, anti-oxidant, and many more. They are also crucial to plants in terms of function. They are aromatic and are present in plants inside specialized cells or glands. Their biosynthesis occurs in the leaves and is present inside them until flowering. After the flowering of the plant, these oils get transferred to the flowers. These essential oils can be extracted using a variety of techniques, including solvent applications, steam distillation, and more. The quality and amount of essential oils in plants are affected by a variety of circumstances. These factors include the development stage of plants, the effect of UV radiation, the effect of Arbuscular mycorrhizal fungi, the effect of light quality, the effect of salt stress, and the effect of fertilizers.<br>]]></description> </item><item><title><![CDATA[Plant as Potential Resources for Efficacious Essential Oils: Underpinning Aromatherapy Evolution]]></title><link>https://www.benthamscience.comchapter/22099</link><description><![CDATA[The basis of healthcare has been medicinal plants from the dawn of humanity. For over 4000 years, people have carefully documented and passed down through generations the various ways in which these have been utilized. The Indian Vedic literature, which dates to roughly 2000 BC, contains a list of around 700 compounds. Cinnamon, spikenard, ginger, myrrh, coriander, and sandalwood are a few of these. Since ancient times, aromatic plant parts and oils have been used for their therapeutic and culinary characteristics, as well as to produce incense, perfumes, cosmetics, and for incense sticks. Ritual use was widespread in early cultures, where it served both sacred and therapeutic objectives that were intricately intertwined. Since prehistoric times, plant essential oils have been utilized in foods, aromatherapy, perfumes, cosmetics, spices, and alimentation. They have also been applied in other medical procedures and phytotherapy. In the current era of pharmaceutical science, interest in herbal medicines has grown relative to conventional or synthetic treatments because they are more affordable, more widely accepted, compatible with human physiology, and have fewer adverse effects. The medicinal properties and applications of an expanding number of emerging essential oils have been researched and documented by pharmacists. The interest in analysing their bioactivity has progressed owing to their widespread use, particularly the recently investigated antibacterial, antioxidant, anticancer, and antidiabetic effects. The traditional Indian or Ayurvedic system of medicine, as well as other ecumenical customary systems, would be transformed if plant predicated knowledge were to be incorporated. The uses of numerous plants for therapeutic, medical, aesthetic, psychological, olfactory, massage, aromatherapy, and other associated issues are examined in this chapter.<br>]]></description> </item><item><title><![CDATA[Physician-Assisted Suicide - The Ethical Insights]]></title><link>https://www.benthamscience.comchapter/22066</link><description><![CDATA[PAS is opted for when the patient is terminally ill and he/she no longer wants to continue life-supporting treatments that are often excruciating, financially unaffordable and offer no hope for survival to terminally ill patients. This chapter talks about the ethical concern of physician-assisted suicide (PAS), which is one of the perennial ethical problems of medicine, how it can be distinguished from euthanasia, and what are the different types of practices that constitute end-of-life procedures. It talks about the factors that make PAS a legal and ethical issue. Furthermore, PAS’s prevalence across the world, especially in Pakistan, is discussed, and also the causative factors leading to PAS have been shed light upon. Moreover, the influence it has on individuals and society and the ways by which we can address issues encountered as a result of physician-assisted suicide are made part of this discussion.<br>]]></description> </item><item><title><![CDATA[Nicotine]]></title><link>https://www.benthamscience.comchapter/22011</link><description><![CDATA[Nicotine is present in the tobacco products. Once smoked, nicotine immediately reaches the brain and binds with nicotinic receptors causing damage to the brain cells. The adolescent brain is especially very sensitive to products such as e-cigarettes, nicotine, and tobacco. Chronic nicotine exposure causes permanent brain damage and cognitive decline. Interestingly there are reports on the use of nicotine and its effects on the epigenetic changes in the brain. These kinds of changes may prepare the brain for further abuse of various illegal drugs. As a result of chronic nicotine exposure brain infarcts, white matter hyperintensities, brain atrophy, and dementia are also known to occur. Neurodevelopment in children is potentially harmed due to exposure to nicotine and nicotinic products. This is due to the inflammation, atherosclerosis, and oxidative stress to the neuronal cells. Pregnant mothers and people who are at risk of developing neurodegenerative disease need to be forbidden from using nicotine. Nicotine can be dangerous when taken with alcohol as it can lead to depression and neurocognitive decline. This chapter addresses the effects of nicotine on the adolescent and adult brain.<br>]]></description> </item><item><title><![CDATA[Alcohol]]></title><link>https://www.benthamscience.comchapter/22010</link><description><![CDATA[Alcohol affects brain activity in various ways. It has both short-term and long-term effects. It causes slurred speech, short-term memory dysfunctions hallucinations, etc. by timing the activity of neuronal cells. Moreover, it causes teratogenic effects in the fetus ifthe mother is consuming alcohol during pregnancy. Alcohol can damage the brain cells, cause a lowering of serotonin levels, and higher GABA levels, cease new brain cells to be formed, and cause damage to the blood vessels and nerve cells in the brain. In addition, alcohol abuse causes WernickeKorsakoff’s syndrome, which is due to the lack of vitamin B1 in drinkers. Also, alcohol abuse causes Wernicke’s encephalopathy which is characterised by muscle problems, being confused, etc. Memory loss and less coordination are the long-term effects of alcohol abuse. All regions of the brain, such as the cerebellum, limbic system, and cerebral cortex, can be affected by alcohol abuse. The cerebellum is responsible for the movement of the body, and alcohol disrupts this balance causing emotional and memory issues. Alcohol consumption on a regular basis leads to reduced brain size or a rapid aging process. Alcohol disorder is listed as one of the most prevalent mental health problems in the world.<br>]]></description> </item><item><title><![CDATA[Methamphetamine]]></title><link>https://www.benthamscience.comchapter/22006</link><description><![CDATA[Methamphetamine (METH) is a highly addictive stimulant that affects the central nervous system. It is a widely abused psychostimulant. Monoaminergic neurotransmitter terminals are affected by METH intake. METH structure is very similar to amphetamine, a drug used to treat attention-deficit hyperactivity disorder (ADHD). METH is taken in various modes, such as smoking, swallowing, snorting, injecting powder, etc. Dopamine levels, serotonin levels, and norepinephrine levels are increased due to METH uptake, leading to extremely strong euphoric effects. This dopamine surge causes the brain to repeatedly take the drug and is responsible for addiction. As a short-term effect, METH causes increased wakefulness and physical activity, decreased appetite, faster breathing, rapid and/or irregular heartbeat, increased blood pressure, and body temperature. METH overdose causes hyperthermia and convolution, which can lead to death if not treated. METH also causes irreversible brain damage. Amphetamine psychosis, dementia-like symptoms, increased anti-social behaviour, and increased susceptibility to neurodegenerative diseases are the long-term neurological effects of METH use.<br>]]></description> </item><item><title><![CDATA[Heroin and its Effects on the Brain]]></title><link>https://www.benthamscience.comchapter/22003</link><description><![CDATA[As per the Drug Enforcement Administration (DEA) and the Controlled Substances Act (CSA) reports, heroin is a Schedule I drug. Heroin causes addiction to the brain like any other addictive substance. Heroin addiction has both long-term and short-term effects on the body. The brain has natural opioid receptors. Heroin is a synthetic opioid. When taken regularly, the brain stops making its own natural opioids. This affects the pain/reward system and causes withdrawal symptoms in patients. Heroin addiction damages the brain's reward system and breathing. Less breathing causes less oxygen supply to the brain. There are reports that state that dementia-like situation is created in the brain due to heroin abuse. Heroin lipophilicity allows the entry of it into the Blood Brain Barrier. μ-opioid receptors (MOR), causing the addictive effects of the heroin in the brain. Dementia symptoms, memory issues, and mental health changes like depression or anxiety are the symptoms that are caused by heroin abuse. Both individual and environmental factors influence a person's ability to abuse heroinanopioid which provides intense feelings of pleasure.&nbsp;<br>]]></description> </item><item><title><![CDATA[Pathogenesis of Atherosclerosis and Coronary Heart Disease: Epidemiology, Diagnostic Biomarkers and Prevention by Nutraceuticals, Functional Foods, and Plant-Derived Therapies]]></title><link>https://www.benthamscience.comchapter/21850</link><description><![CDATA[Atherosclerosis is characterized by hardening/narrowing of arteries and reduction of blood flow to vital organs. Animal models and human research show that endothelial dysfunction and plaque development precede the pathogenesis of atherosclerosis, and related coronary heart disease, neurological, and renal disorders. Cardiac CT-scans are used to detect atherosclerosis. Early diagnosis of atherosclerosis reduces mortality, morbidity, and healthcare expenditures. Biomarkers like C-reactive protein, IL-6, IL-8, phospholipase A2, cardiac troponin, MicroRNA, miR-21, and other endothelial inflammation biomarkers are novel targets for monitoring atherosclerosisrelated cardiovascular disorders. Anti-platelet and anti-cholesterol drugs are used in the treatment of atherogenesis and blood vessel clots. However, cholesterol-lowering drugs may cause serious adverse effects. Thus, safe and cost-effective non-pharmacological anti-atherogenic and anticoagulant therapies are urgently needed. Nutraceuticals, functional foods, plant-derived therapies, antioxidant/anti-inflammation, foods/fruits/vegetables, and lifestyle changes (e.g., physical activity, less alcohol, smoking cessation) reduce atherogenesis, diabetes mellitus, obesity, hypertension, LDL, and C-reactive protein in all age groups, especially younger people. Overwhelming evidence suggests that regular physical activity (30 min/day), cessation of cigarette smoking, and consumption of antioxidant nutraceuticals rich in flavonoids and retinoids, fresh vegetables and fruits, omega-3 PUFA, culinary spices, probiotics, Mediterranean-type diet, and “DASH DIET” lower the risk of atherogenesis and cardiovascular diseases. This review summarizes current advances in the diagnosis and management of atherosclerosis and related cardiovascular illnesses with plant-based and wholesome diets, including the Mediterranean diet, DASH DIET, and lifestyle changes. New preventative measures and alternative therapies, including dietary interventions and plant-based foods may be the most cost-effective ways to manage atherosclerosis and cardiovascular illnesses. <br>]]></description> </item><item><title><![CDATA[Oxidative Stress and Protein Misfolding in Skin Aging]]></title><link>https://www.benthamscience.comchapter/21845</link><description><![CDATA[Aging is a visible indicator of malfunctioning or toxic proteins that sensitize other proteins to oxidative damage which is most prominently observed on the skin. Protein misfolding is caused by the protein following an incorrect folding pathway which may lead to spontaneous misfolding while oxidative stress refers to the disruption of the balance between antioxidant defenses and reactive oxygen species production. Oxidation may alter noncovalent interactions within proteins, peptide chain fragmentation, and protein cross-linking, which causes protein misfolding and further skin aging. A feedback loop is observed in all three processes. A proper understanding of these events is significant in the formulation of anti-aging preparations and further understanding of the mechanism of aging. In this Chapter, we will be discussing some natural antioxidants available to combat oxidative stress which facilitate healthy aging and normal functioning of the body. We will be elaborating on the body’s natural defense mechanism against these problems such as the role of Chaperones. We will be looking at the detailed mechanism of oxidative stress, protein misfolding, and their correlation with skin aging along with factors influencing it. The biomarkers for oxidative stress will be enlisted. A brief correlation between these processes in a test worm and how it correlates to humans and its importance will be explained in this chapter.<br>]]></description> </item><item><title><![CDATA[Food Color, Taste, Smell, Culinary Plate, Flavor, Locale, and their Impact on Nutrition: Present and Future Multisensory Food Augmentation and Noncommunicable Disease Prevention: An Overview]]></title><link>https://www.benthamscience.comchapter/21844</link><description><![CDATA[Cognizant that ‘the world is one family’, this overview describes chemosensory characteristics of food and related issues that may enable global inequalities in healthy food consumption to be improved with a reduction in noncommunicable diseases (NCDs), preventatively. Past and modern aspects of food tradition are briefly described followed by titular chemosensory characteristics and their potential application to improving health in nutrition in the sense intended, including the culinary plate. Human-computer interface and food augmentation reality and commensal dining, in association with chemosensory properties, including sound concerning oral food processing, are described. Future research on arresting trends in the prevalence of NCD is suggested based on the literature. Visual cues for in-store food choice are discussed that potentially allow the consumer, through psychological processes and behavior outcomes, to be more discerning. Advertisements and store architecture per se are not discussed. The relatively high prevalence of anosmia caused by COVID-19 infection relative to non-infected subjects may alter taste and flavor perception and lead to changed dietary habits and metabolism. Most global consumers can practice the ‘how’ and ‘when’ to beneficially eat but food insecurity poses a global problem.<br>]]></description> </item><item><title><![CDATA[Human Diseases and Recent Biotechnology Breakthroughs in Curbing Diseases]]></title><link>https://www.benthamscience.comchapter/21755</link><description><![CDATA[Medical biotechnology represents a field in continuous progress and today has revolutionized how illnesses are diagnosed and treated. A look at the latest medical biotechnological breakthroughs shows how biotechnology innovations are changing medicine. Recently, we saw how biotechnology affected efforts to combat the coronavirus disease 2019 (COVID-19) pandemic on the world's health. The scientific community has been working assiduously to develop effective treatments for the prevention and management of other diseases, such as cancer, human immunodeficiency virus (HIV), cardiovascular disease, diabetes mellitus, and neurodegenerative disorders such as Alzheimer's disease, along with other dementia variants that stand out among the leading causes of mortality worldwide. This effort has recently resulted in the development of RNA vaccines. Some of the most promising biotechnological developments include gene therapy to alter an individual's genetic makeup through diverse techniques, immunotherapeutic methods that bolster the body's natural immune defense mechanisms, and precision medicine strategies in which treatment is personalized to a patient's genetic profile. This chapter provides an overview of the most prevalent and deadly human diseases with a focus on recent biotechnological breakthroughs.<br>]]></description> </item><item><title><![CDATA[Drug Repurposing in CNS and Clinical Trials: Recent Achievements and Perspectives Focusing on Epilepsy and Related Comorbidities]]></title><link>https://www.benthamscience.comchapter/21743</link><description><![CDATA[Central Nervous System (CNS) disorders are a massive burden on the global health system, including a broad range of clinical conditions, such as epilepsies, depression, dementia, multiple sclerosis, and Parkinson’s disease. Permanent efforts are being made to find early, non-invasive, and effective diagnostic methods, as well as efficient and safe drug-based treatments for CNS conditions. Nevertheless, many patients displaying these clinical conditions still face the lack of an effective pharmacotherapy to cure the diseases or at least to properly control the progression of symptoms. Currently, epilepsies present an estimated prevalence of 0.5%–1% worldwide, and around 30% of the patients remain refractory to the available drug treatment. The comorbidities that affect epileptic patients, such as cognitive impairment and depression, are major public health challenges. This scenario highlights the urgent need for approving new therapeutic tools for CNS diseases. A successful development process of a new compound presenting therapeutic potential can range up to 20 years and cost hundreds of millions of US dollars, from the initial characterization of the in vitro chemical and biological properties until clinical trials. Additionally, drug development has a low success rate in the case of CNS conditions. In this context, drug repurposing (or drug repositioning, DR) is an alternative way to reduce the cost and accelerate the process of a drug-based treatment approach since it identifies a novel clinical application for an existing compound already approved for a distinct indication. In the present chapter, we aim to describe recent outcomes of DR aiming at CNS pathological conditions, especially discussing the recent clinical trials and their impacts on future endeavors in the search for the management of epilepsies and related comorbidities.<br>]]></description> </item><item><title><![CDATA[Role of Gut Microbiota in Neuroinflammation and Neurological Disorders]]></title><link>https://www.benthamscience.comchapter/21741</link><description><![CDATA[The prevalence of neurological diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple sclerosis (MS) are growing in the world, but their pathogenesis is unclear and effective treatment does not exist. Neuroinflammation is associated with many neurodegenerative mechanisms involved in neurodegenerative diseases. The human gut microbiota is an aggregate of microorganisms that live in the gastrointestinal tract (GIT) that plays a crucial role in maintaining human health and the pathogenesis disease condition. The microbiota can affect neuronal function through neurotransmitters, vitamins, and neuroactive microbial metabolites like shortchain fatty acids. The change in gut microbiota architecture causes increased permeability of the intestine and immune system activation, contributing to systemic inflammation, neurological injury, and eventually neurodegeneration. Available data suggest that the microbiota send signals to the central nervous system (CNS) by activating afferent neurons of the vagus nerve via neuroendocrine and neuroimmune pathways. The molecular interaction between the gut/microbiome and CNS is complex and bidirectional, ensuring gut homeostasis and proper digestion. Evidence suggests that dysfunction of the gut-brain axis could be a significant factor leading to many disorders of CNS. In this chapter, we explore how the gut microbiome may affect brain function and the development of neurological disorders. In addition, we are also trying to highlight the recent advances in improving neurological disease by supplemental probiotics and faecal microbiota transplantation via the concept of the gut-brain axis to combat brain-related dysfunction.<br>]]></description> </item><item><title><![CDATA[Recent Drugs Tested in Clinical Trials for Alzheimer´s and Parkinson´s Diseases Treatment: Current Approaches in Tracking New Drugs]]></title><link>https://www.benthamscience.comchapter/21739</link><description><![CDATA[Affecting more than 50 million people worldwide and with high global costs annually, neurological disorders such as Alzheimer's disease (AD) and Parkinson’s disease (PD) are a growing challenge all over the world. Globally, only in 2018, AD costs reached an astonishing $ 1 trillion and, since the annual costs of AD are rapidly increasing, the projections estimate that these numbers will double by 2030. Considering the industrial perspective, the costs related to the development of new drugs are extremely high when compared to the expected financial return. One of the aggravating factors is the exorbitant values for the synthesis of chemical compounds, hindering the process of searching for new drug candidates. In the last 10-year period, an average of 20 to 40 new drugs were approved per year, representing a success rate of less than 6%. However, the number of referrals for new drug orders and/or applications remained at approximately 700 each year, reinforcing the difficulty in the process of identifying and developing novel drugs. Regarding neurodegenerative diseases, the FDA (USA) approved 53 new therapies in 2019, including 48 new molecules and, from these, three are medicines and two are vaccines. The main drugs recommended for the treatment of these disorders are included in the following classes: Dopamine supplement (Levodopa), Monoamine oxidase (MAO) inhibitor (Selegiline, Rasagiline), Dopamine agonist (Apomorphine, Pramipexole), and Acetylcholinesterase inhibitor (Donepezil, Rivastigmine, Galantamine). Additionally, the current pharmacological treatments are not able to cure these patients and considering the etiological complexity and the prevalence of neurological disorders, scientists have a great challenge in exploring new therapies and new molecules to find an adequate and viable treatment for these diseases. Clinical trials are essential in this process and thus, this chapter describes the most important drugs that were targets of phase III and IV clinical studies in the last five years, associated with the most common neurological disorders worldwide, AD and PD. Information about mechanisms of action, experimental studies in other diseases that support their use, and chemical structure of the drugs are included in this chapter. Additionally, nature as a source of valuable chemical entities for PD and AD therapeutics was also revised, as well as future advances in the field regarding tracking new drugs to get successful results and critical opinions in the research and clinical investigation.<br>]]></description> </item><item><title><![CDATA[Prognosis of Dementia using Machine Learning]]></title><link>https://www.benthamscience.comchapter/21730</link><description><![CDATA[The brain is one of the most sensitive parts of the human body which transmits millions of signals every moment. Dementia is the most emerging brain health issue which involves memory loss, difficulty in problem-solving, handling complex tasks, etc. Dementia is a syndrome that causes a loss of mental ability. It affects memory, thinking, shape, comprehension, counting, reading ability, language, and judgment. Dementia affects millions of people and can be the leading cause of death. It is now the seventh leading cause of death worldwide, as well as one of the major causes of impairment and reliance on elderly people. There is no treatment for dementia at present. The importance of early detection and diagnosis in improving early and effective management is crucial. Predicting dementia in advance can lead us to a better life. To predict dementia, various Machine Learning models have been used. In this paper, Dementia is predicted on the basis of MRI Images, for this, three different datasets of MRI Images have been collected. Furthermore, for better prediction, various Machine learning models are used to predict dementia and validate the performance with statistical analysis like K-Nearest Neighbours, XG Boost, Support Vector Machine, Random Forest Algorithm (RFA), and Convolutional Neural Network (CNN). Out of all algorithms, Random Forest Algorithm and Convolutional Neural Network gave the best result with the accuracy of 93.2 and 99.9 respectively.<br>]]></description> </item><item><title><![CDATA[Preface]]></title><link>https://www.benthamscience.comchapter/21722</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Biomaterials and Mesenchymal Stem Cells]]></title><link>https://www.benthamscience.comchapter/21645</link><description><![CDATA[Mesenchymal stem/stromal cells are splendid cell sources for tissue engineering and regenerative medicine attributed to the unique hematopoietic-support and immunomodulatory properties as well as the multi-dimensional differentiation potential towards adipocytes, osteoblasts, and chondrocytes in vitro and in vivo. To date, MSCs have been identified from various approaches, such as perinatal tissues, and adult tissues, and even derived from human pluripotent stem cells (hPSCs). Longitudinal studies have indicated the ameliorative effect and therapeutic efficacy upon a variety of refractory and recurrent disorders such as acute-on-chronic liver failure (ACLF), acute myeloid leukemia (ACLF), premature ovarian failure (POF), and intractable wounds. To date, MSCs have been a to have various origins, including mesoderm, endoderm and ectoderm. In this chapter, we mainly focus on the concepts, and biological and therapeutic properties of MSCs, together with the standardizations for industrial transformation. Overall, the descriptions would help promote a better understanding of MSCs in disease pathogenesis and management and benefit the preclinical and clinical applications in the future.<br>]]></description> </item><item><title><![CDATA[The Role of Emerging Technologies in Smart Health Care]]></title><link>https://www.benthamscience.comchapter/21612</link><description><![CDATA[Numerous technological advancements like 3-D Printing, Virtual Reality (VR), Augmented Reality (AR), Artificial Intelligence (AI), Internet of Things (IoT), Drones, Robots, and Blockchain are now being inscribed for their ability to change the health care industry and make it a more automated and effective field. Various tools related to AI, like Google, DeepMind, Atomwise, Chatbot, Enlitic, Freenome, and Buoy Health, are helpful in makingthe health industry more efficient. There is another technology which is nanomicelle that can be used for effective drug delivery to treat various cancers, including breast, colon, and lung cancer. Moreover, self-assembling peptide nanoparticles that were prepared from SARSCov-1 spike (S) protein, successfully induced neutralizing antibodies against the coronavirus, subsequently preventing infection of Vero cells. Furthermore, the application of 3D printing in medicine can provide many benefits, including the customization and personalization of medical products, drugs, and equipment; cost-effectiveness; increased productivity; democratization of design and manufacturing; and enhanced collaboration. IoT enables real-time alerting, tracking, and monitoring, which permits hands-on treatment, better accuracy, apt intervention by doctors, and improves patient care delivery results. The other most promising application isblockchain in the healthcare sector for identity management, dynamic patient consent, and management of supply chains for medical supplies and pharmaceuticals. In addition, there are several case studies that describe the benefits of emerging tools, like recently the use of Emerging Technologies for the study, diagnosis, and treatment of patients with COVID-19 by using Deep Convolutional neural networks (CNN), which is a widely used deep learning architecture, enabled distinguishing between COVID-19 and other causes of pneumonia through chest X-ray image analysis.<br>]]></description> </item><item><title><![CDATA[Promising Pharmaceutical Compounds of Marine Cnidarians: Their Chemistry and Therapeutic Applications]]></title><link>https://www.benthamscience.comchapter/21598</link><description><![CDATA[This chapter deals with the promising secondary metabolites of the different constituents of marine cnidarians viz. hydrozoan medusae, scyphozoan medusae and soft corals and their bioactivities. Among the chemical classes of compounds, terpenoids ranked first and cytotoxicity of these compounds was the major activity.&nbsp;<br>]]></description> </item><item><title><![CDATA[Moringa oleifera Lam.: An Updated Review on Micropropagation and Pharmacological Properties]]></title><link>https://www.benthamscience.comchapter/21563</link><description><![CDATA[Moringa oleifera Lam. tree is considered a miracle tree due to its nutrientrich profile. This plant has been widely cultivated throughout the world for its medicinal and nutritional benefits. Moringa plant contains a significant amount of various phytochemicals such as alkaloids, flavonoids, saponins, tannins, and phenolics that are responsible for their various medicinal, nutritional, and other applications. The use of moringa in pharmacological drugs not only increases cultivation but also increases the over-exploitation of this tree. As the conventional methods of moringa reproduction are not much effective, we require additional alternative strategies to multiply moringa plants. Micro-propagation is considered an effective method to produce a large number of transplants within a short time period. This chapter explores the micro-propagation approaches of M. oleifera together with its nutritional profile and biological activities.&nbsp;<br>]]></description> </item><item><title><![CDATA[Hormoneal Therapy]]></title><link>https://www.benthamscience.comchapter/21551</link><description><![CDATA[Treatments that involve the use of hormones or their antagonists are commonly referred to as hormone therapy or hormonal therapy. Oncologic hormone therapy, hormone replacement therapy (HRT), androgen replacement therapy (ART), oral contraceptive pills and gender-affirming hormone therapy are the major classes of hormonal therapy in addition to a few others. Some hormonal therapies will be discussed in detail under different chapters including oncologic hormone therapy, glucocorticoids and mineralocorticoids and insulin under antineoplastic agents, antiinflammatory steroids and antidiabetic agents, respectively. After studying this chapter, students will be able to: <br><br>• Define and classify hormonal therapy and differentiate between hormonal therapy and treatment. <br><br>• Explain all types of hormone replacement therapy including menopausal, androgens, and oral contraceptives.<br><br>&nbsp;• Discuss the use of androgen replacement therapy (ART) in males with low levels of testosterone due to disease or aging. <br><br>• Describe gender-affirming hormone therapy such as feminizing hormone therapy and masculinizing hormone therapy. • Identify appropriate growth hormone therapy for growth hormone deficiency. <br><br>• Demonstrate understanding of thyroid hormone replacement in hypothyroidism and antithyroid therapy in hyperthyroidism. <br><br>• Demonstrate clear guidance to the use of oral contraceptive pills for various purposes including birth control.&nbsp;<br>]]></description> </item><item><title><![CDATA[Animal Models of Alzheimer's Disease]]></title><link>https://www.benthamscience.comchapter/21465</link><description><![CDATA[As the number of Alzheimer's Disease (AD) cases continues to climb throughout the third decade of this century, researchers have yet to find a cure for the debilitating disease, even though the condition was first diagnosed in the early 1900s. Since then, scientists have elucidated its etiology, which shows that AD pathogenesis is a unique, complex amalgam of genetic, aging, comorbidities, and environmental factors for each patient. In no small part, animal models of AD have been instrumental in revealing disease pathways correlated to cognitive dysfunction and behavioral deficits; moreover, they have been indispensable as preclinical models for potential drug candidates. Both small and large mammalian models of AD will be surveyed and discussed, ranging from mice and rats to dogs, cats, sheep, pigs, and primates. Each of the model's advantages and disadvantages will be closely examined.&nbsp;<br>]]></description> </item><item><title><![CDATA[Diagnosis and Potential Strategies to Discover New Drugs for the Treatment of Alzheimer’s Disease (AD)]]></title><link>https://www.benthamscience.comchapter/21420</link><description><![CDATA[Alzheimer disease (AD) is most common cause of dementia, which is characterized by impaired cognitive and behavioural charateristics. Deposition of Aβ plaques and neurofibrillary tangs (NFTs) are the hallmark of AD. Generally it is a chronic disease where neurodegeneration, and loss of neuronal function arise earlier before it is diagnosed. Early detection of AD is important as it reduces the severity of the disease. In this regard, an effective tools/methods are available including CSF biomarkers, Magnetic Resonance imaging (MRI), Positron emission tomography (PET) but all these methods are painful and often cannot be afforded by the patients. <br><br>Therapy of AD includes inhibitors of choline esterases, and antagonists at NMDA receptors. From the studies it is shown that these drugs just offer relief from symptoms rather than alleviating the progression of disease. Multiple pathological processes contribute for AD, like oxidative stress, dysregulation of neurotransmitters, inflammation of neurons, aggregation β-amyloid, phosphorylation of tau protein. It is essential to target multiple causes for an effective outcome in the treatment of AD. Early diagnosis is also crucial as it reduces disease progression thereby cost involved in AD therapy. <br><br>This review focuses on non-invasive, patient affordable diagnosis methods and also potential targets to discover new drugs beyond conventional and available drugs.<br>]]></description> </item><item><title><![CDATA[Novel Treatment for Alzheimer’s Disease: Tapping the Somatostatin-evoked Aβ Catabolism via α-endosulfine-K<sub>ATP</sub> Channel Pathway]]></title><link>https://www.benthamscience.comchapter/21419</link><description><![CDATA[Alzheimer's disease (AD) is a debilitating neurological disease that is known to worsen as people age. As a chronic illness, it has a negative impact on the health and financial well-being of patients and their families. Despite decades of research into new medications and therapy regimens, the therapeutic choices for these conditions are still limited. Although currently available medications for AD do not prevent or stop disease progression, they are used to treat symptoms and provide brief comfort to patients. The development of medications and other therapy modalities to address the unmet medical need has sparked a surge of interest in understanding the mechanism of AD in recent years. Growing bodies of evidence direct towards the treatment of AD by intercepting the Somatostatin-evoked Aβ catabolism in the brain, via the α-endosulfin-KATP channel pathway. The latter can be achieved through the repurposing or repositioning of drugs previously approved by the regulatory authorities and indicated in other diseases. With the advent of technology in the healthcare sector, these could be corroborated through various in-silico and in-vitro techniques. This article aims to explore the various aspects of the byzantine α-endosulfine-KATP channel pathway while providing information and future prospects for the development of new therapies to combat AD.<br>]]></description> </item><item><title><![CDATA[Effects of Carbonic Anhydrase Inhibitors on Mitochondrial Dysfunction and Consequently on Alzheimer’s Disease]]></title><link>https://www.benthamscience.comchapter/21418</link><description><![CDATA[With the discovery of Carbonic Anhydrase (CA) and its isoenzymes in various Alzheimer’s disease (AD) models and the brain of AD patients, the role of CA in AD pathology has become of keen interest among scholars around the world. Several experiments were performed to investigate the same, albeit they didn’t provide us with the exact mechanism through which CAs are involved in AD progression, but they gave us an important insight into the beneficial outcomes of CA inhibition. Carbonic Anhydrase Inhibitor (CAI) administration showed a significant reduction in the release of the proapoptotic factor- Cytochrome C (cyt C) from the challenged mitochondria (under oxidative stress). Thus, a link between ageing, oxidative stress, mitochondria dysfunction and pathogenesis of Alzheimer’s disease was established. Treatment with CAI indirectly lowers neuronal loss and, thus, cognitive impairment, which are characteristic features of AD. Though, the precise functions of CA in exaggerating or mediating AD still remain hazy, with the support of various scholarships globally, the use of CAII (an isoenzyme of CA) as a potential biomarker for AD can be proposed.<br>]]></description> </item><item><title><![CDATA[Promising Nano-Carriers-Based Targeted Drug Delivery Approaches for the Effective Treatment of Alzheimer’s Disease]]></title><link>https://www.benthamscience.comchapter/21417</link><description><![CDATA[Alzheimer’s disease (AD) is an attained disorder of cognitive and behavioral impingement with progressive symptoms over time. It is mostly witnessed in elderly people, and as per the World Health Organization (WHO), it has affected more than 35 million people worldwide, and this figure is presumed to double by the year 2050. The most commonly believed cause of AD is the accumulation of beta-amyloid, which forms extracellular plaques. Presently conventional therapy for treating cognitive impairments in AD relies on a neurotransmitter or enzyme modulation strategy. Conventional approved drugs, such as acetylcholinesterase inhibitors (memantine, tacrine), are widely available for the treatment of mild to moderate AD, but due to their lower bioavailability, poor solubility, and ineffective capability to surpass the blood brain barrier (BBB), they often fail to produce the desired effect. The potency of conventional AD drugs is highly dependent on various physiological aspects such as BBB; blood-cerebrospinal fluid barrier and drug efflux by P-glycoprotein, which all hampers the capabilities of AD drugs to grasp the central nervous system (CNS). So, in order to conquer the hurdle and these existing limitations faced by CNS drugs to cross the BBB, innovative pathways in drug development have become the need of the hour. Various nanocarriers based approaches profitably meet this demand by improving the efficacy as well as facilitating the sustained release of the entrapped AD drug via targeted drug delivery. The blood-brain barrier offers protection to the central nervous system and also limits the entry of therapeutic molecules to the CNS. On the other hand, nanotechnology offers the possibility to deliver small molecules against CNS disorders across BBB due to their enormous properties, such as small surface area, controllable physicochemical properties, higher drug payload, and better drug circulation time. Plenty of nanocarriers and nanoparticle prodrugs have been reported to have inconsequential cytotoxicity in preclinical studies, and these advancements have proclaimed a new juncture for the development of new classes of nano carriers’ based potent drug formulations for the treatment of AD. A plethora of nanotechnology-based approaches such as polymers, emulsions, lipo-carriers, solid lipid carriers, carbon nanotubes, and metal-based carriers have been redefined over time, and they have been successfully focusing on both neuroprotective and neurogenerative techniques for treating AD. Many researchers also reported that nanotechnological-based techniques can improve the early diagnosis of AD and enhance the therapeutic efficacy and bioavailability of drugs.<br>]]></description> </item><item><title><![CDATA[Tau Protein: Targets And Development Against Alzheimer’s Disease]]></title><link>https://www.benthamscience.comchapter/21416</link><description><![CDATA[The clinical manifestations of Alzheimer's disease (AD) and associated human tauopathies are driven by tau neuronal and glial abnormalities. Tau, a microtubule-associated protein is inherently disordered due to its lack of a stable structure and great flexibility. Intracellular inclusions of fibrillar tau with a sheet shape accumulate in the brains of individuals with AD and other tauopathies. As a result, tau separation from microtubules and tau transition from a disordered state to an inappropriately aggregated state are critical steps before the start of tau-related illnesses. Many studies have demonstrated that this shift is triggered by post translational changes such as hyperphosphorylation and acetylation. Before the development of tau inclusions, the misfolded tau self-assembles and forms a tau oligomer. Animal and clinical research utilising human samples has shown that tau oligomer development contributes to neuronal death. During tauopathies, tau seeds are released from cells and absorbed into neighbouring cells, resulting in the spread of abnormal tau aggregation. Thus, Tau has become both a physiological and pathological target for AD treatments during the last decade. Evidence reveals many potential techniques for preventing tau-mediated toxicity: (1) direct suppression of pathological tau aggregation; (2) inhibition of tau post-translational changes that occur before pathological tau aggregation; (3) inhibition of tau propagation; and (4) microtubule stabilisation. Aside from traditional low-molecular-weight compounds, newer drug discovery approaches, such as the development of medium-molecular-weight drugs (peptide- or oligonucleotide-based drugs) and high-molecular-weight drugs (antibody based drugs), provide alternative pathways to preventing the formation of abnormal tau. Suppression of protein kinases or protein-3-O-(N-acetyl-beta-D-glucosaminl)-L-serine/threonine hydrolase, inhibition of tau aggregation, active and passive immunotherapies, and tau silencing using antisense oligonucleotides; in several animal models, have shown the capacity to prevent or minimise tau lesions and treat either cognitive or motor impairment. Immunotherapy, which has already reached the clinical stage of drug development, is the most advanced technique for treating human tauopathies. Tau vaccines or humanised antibodies are designed to target a range of tauspecies in both intracellular and extracellular environments. Some of them recognise the amino- or carboxy-terminus, while others have proline-rich areas or microtubule binding domains that they can attach to. In this review, we examine various clinical targets for the treatment of tauopathies as well as the various molecules researched as tau inhibitors that can be used in AD. Furthermore, we explore the efficacy of some of the prominent molecules in clinical studies for tau-targeted therapies research. <br>]]></description> </item><item><title><![CDATA[Enzymatic Targets for Drug Discovery Against Alzheimer's Disease]]></title><link>https://www.benthamscience.comchapter/21415</link><description><![CDATA[Alzheimer’s Disease (AD) is a neurodegenerative disease. The disease itself is progressive and full recovery from it isn’t achievable yet. There are several hypotheses asserted (Cholinergic hypothesis, Amyloid hypothesis etc.) to explain the mechanisms behind the disease. Also, many targets have been identified for possible therapeutics and from these targets, numerous drug candidates have been evaluated in clinical trials. Unfortunately, most of these trials failed due to the enigmatic nature of this disease. Currently, there are 7103 targets associated with Alzheimer's disease listed in the Open Targets platform where 1240 of them are enzyme-related. In this chapter, enzymatic targets of the AD have been reviewed, and those claimed to have disease modifying effects were selected and presented according to their clinical significance.<br>]]></description> </item><item><title><![CDATA[Memantine and Glutamate Antagonists in the Treatment of Alzheimer's Disease: Current Updates]]></title><link>https://www.benthamscience.comchapter/21414</link><description><![CDATA[Alzheimer’s disease (AD) is the most important cause of dementia and a complex chronic neurodegenerative disease. Many of the currently marketed drugs are used to treat this disease condition, but a major issue with these drugs is their neurotoxicity. Alzheimer's treatment with the FDA approval of memantine resolves the neurotoxicity issue. Memantine acts on glutamate and its receptors in the treatment of AD. Recent studies show that NMDA receptor-acting drugs are doing well in the healing of Alzheimer's patients, because of their selectivity on receptor and neuroprotective activity. The present work is an attempt to collect updated information about memantine and glutamate antagonists used for the treatment of AD.&nbsp;<br>]]></description> </item><item><title><![CDATA[Tubulin Modifying Enzymes as Target for the Treatment of Alzheimer's Disease: Old Perspective With A New Angle]]></title><link>https://www.benthamscience.comchapter/21413</link><description><![CDATA[Alzheimer's disease (AD) is a major cause of mental disability in the elderly, accounting for 50-60% of all dementia. While β-amyloid plaques as well as neurofibrillary tangles are neuropathological markers, inflammation plays a critical role in AD development. The aberrant detachment of microtubules (MTs) from axon MTs, cellular mislocalization, and hyperphosphorylation of tau are major factors in neurodegeneration death. Tau's ability to aggregate as well as form NFTs is assumed to be regulated by post-translational changes, which are regarded to be an essential regulatory mechanism. So far, drugs that target tau phosphorylation as well as aggregation have not shown therapeutic impact. It is now clear that tubulin PTMs cause tau dysfunction. High glutamylation and detyrosination levels in the neurons affect MT surface physicochemical characteristics. Further evidence for the relevance of such an enzymatic machinery in neurobiology comes from the recent discovery of harmful mutations in enzymes involved in surface MT modification. In this chapter, we discussed that targeting tubulin-modifying enzymes pharmacologically may be useful in treating neurodegenerative disorders.<br>]]></description> </item><item><title><![CDATA[TMP21 in Alzheimer’s Disease: An Important Target For Effective Treatment Approach]]></title><link>https://www.benthamscience.comchapter/21412</link><description><![CDATA[Alzheimer's disease (AD) is the most prevalent form of dementia, and it is considered a dynamic cognitive decline. Neurofibrillary tangles and nerve cell injury are important neuropharmacological symptoms for one AD brain. TMP21 is an important molecule in cellular protein trafficking. TMP21, a protein involved in the production of neurotic plaques, appears to be dysregulated in AD. As a result, we want to look into TMP21 dysregulation in Alzheimer's disease, as well as the involvement of TMP21 in neurotic plaque development and the underlying mechanisms. TMP21's significance in the creation of neurofibrillary tangles, synaptic disbalance, and nerve cell death is also explored. It will shed light on the therapeutic potential of regulating TMP21 as a treatment for AD.<br>]]></description> </item><item><title><![CDATA[Recent Advances In Tacrine-Based Anti-Alzheimer’s Drug Design]]></title><link>https://www.benthamscience.comchapter/21411</link><description><![CDATA[Alzheimer’s has become a common disease in aged people that leads to cognitive impairment and finally results in dementia and death. As the disease has a complicated etiology, it can hardly be prevented and cured. Hence, it turned out to be one of the menacing neurodegenerative diseases. The important concerning factor about Alzheimer’s is its unaffordable treatment cost. Also, there are only a few efficient anti-Alzheimer drugs. Now, it is a very urgent need to discover the most efficient and cost-effective anti-Alzheimer’s drugs. Nowadays, research reveals drugs based on heterocyclic scaffolds that have attributed to potent pharmacology. Quinoline-containing molecule, tacrine was recommended as an acetylcholinesterase inhibitor. However, its use has been withdrawn because of its toxicity. While research is going on designing derivatives of tacrine. Fortunately, some tacrine derivatives showed the most potent anti-Alzheimer properties. In view of this, here, anti-Alzheimer properties of recently reported tacrine-based Alzheimer’s agents are discussed and evaluated. The structure-activity relationship has been helpful in identifying potent molecules in a series of derivatives.<br>]]></description> </item><item><title><![CDATA[Epigenetics of Alzheimer’s Disease: Past, Present and Future]]></title><link>https://www.benthamscience.comchapter/21410</link><description><![CDATA[Alzheimer’s disease (AD) exemplifies a looming epidemic lacking effective treatment and manifests with the accumulation of neurofibrillary tangles, amyloid-β plaques, neuroinflammation, behavioral changes, and acute cognitive impairments. It is a complex, multifactorial disorder that arises from the intricate interaction between environment and genetic factors, restrained via epigenetic machinery. Though the research progress has improved the understanding of clinical manifestations and disease advancement, the causal mechanism of detrimental consequences remains undefined. Despite the substantial improvement in recent diagnostic modalities, it is challenging to distinguish AD from other forms of dementia. Accurate diagnosis is a major glitch in AD as it banks on the symptoms and clinical criteria. Several studies are underway in exploring novel and reliable biomarkers for AD. In this direction, epigenetic alterations have transpired as key modulators in AD pathogenesis with the impeding inferences for the management of this neurological disorder. The present chapter aims to discuss the significance of epigenetic modifications reported in the pathophysiology of AD such as DNA methylation, hydroxy-methylation, methylation of mtDNA, histone modifications, and noncoding RNAs. Additionally, the chapter also describes the possible therapeutic avenues that target epigenetic modifications in AD.&nbsp;<br>]]></description> </item><item><title><![CDATA[An Overview of In Vivo Imaging Techniques]]></title><link>https://www.benthamscience.comchapter/21377</link><description><![CDATA[Imaging is developing very quickly in various study bases. Nowadays, due to the desire for the technology coming to imaging, it is widely used to detect molecular and structural targets in in vivo studies. The aim of developing new non-invasive imaging methods is to provide affordable, high-resolution images with minimal known side effects for studying the biological processes of living organisms. For this purpose, X-ray-based computed tomography (CT), magnetic resonance imaging (MRI), ultrasound (UI), Nuclear imaging methods (positron emission tomography (PET), single-photon emission computed tomography (SPECT)), and optical imaging, are techniques widely used in imaging. Each of these has unique advantages and drawbacks. The background of imaging techniques and their developments have been shown in this chapter and we discuss in detail the use of optical imaging through bioluminescence, fluorescence, and Cerenkov luminescence techniques in various diseases for preclinical applications, early clinical diagnosis, treatment, and clinical studies.&nbsp;<br>]]></description> </item><item><title><![CDATA[OCT-A Findings and Usefulness in Alzheimer's Disease, Parkinson's Disease, and Systemic Lupus Erythematosus]]></title><link>https://www.benthamscience.comchapter/21361</link><description><![CDATA[The eye is a window to the brain because of its inherent connection to the central nervous system (CNS). Several brain disorders manifest as ophthalmic abnormalities and can be detected through a detailed assessment of the eyes. In the last decade, extensive evaluation of retinal microvascular changes using optical coherence tomography angiography (OCT-A) has been performed for several diseases, such as Parkinson's disease, Alzheimer's disease, and systemic lupus erythematosus. Although the results from the available studies are conflicting (mainly due to heterogeneous study populations), they agree on the applicability of this technology for the early identification of these diseases. This chapter summarizes the OCT-A screening and monitoring uses for these diseases and hypotheses for the potential identification of disease characteristics.<br>]]></description> </item><item><title><![CDATA[Applications of AI-enabled Robotics in Healthcare]]></title><link>https://www.benthamscience.comchapter/21302</link><description><![CDATA[Robotics began roughly 30 years ago in medical applications, but it is still relatively young for biological applications. Because of the precision, accuracy and reproducibility of robotic technology, robotic interventions in medical fields, such as robotic surgery, can enable doctors to work inside the human body, which is either non-invasive or minimally invasive, with improved surgical results. The importance of medical robots in the medical sector is intended to deliver good outcomes to assist people in doing complex tasks that need a significant amount of time, accuracy, concentration, and other routines that cannot be accomplished solely through human capability. Due to advancements in AI and IoT and their convergence to AIoT, the potential of medical robots has tremendously increased in the healthcare industry. The chapter outlines the various applications of robotics in the healthcare sector, including surgical, rehabilitation, telemedicine, and diagnostic. The advantages of robotics in Healthcare are highlighted, along with the discussion on the current and future challenges in their deployment and adoption. The role of AIoT in enhancing these healthcare robots' cognitive and other capabilities is also discussed. Finally, the future of robotics in Healthcare is explored, including emerging trends and technologies, their impact on the healthcare industry, and the potential for innovation and growth.&nbsp;<br>]]></description> </item><item><title><![CDATA[Geofencing For Elderly]]></title><link>https://www.benthamscience.comchapter/21299</link><description><![CDATA[This century has witness a substantial increase in elderly population. Health issues like depression and dementia are more prominent in these elderly populations which demand Assisted Living environment. The engagement of technology is seen as a solution for the Assisted Living environment. With the help of technology, Ambient Assisted Living (AAL) has become a field of research. As AAL strives to seamlessly connect information technology with people's daily lives, the buzz word called Internet of Things (IoT) exhibits significant promise for developing technical solutions in this field. Geo-fencing is one such location sensing tool that uses IOT and GPS for defining geographical boundaries and is used for putting e-fences to the needy people in their ambiances. This article aims to provide a safe tracker environment that allows the elderly people to continue with their daily activities. In this article, application built for elderly people is explained. Through this application, the person gets the direction to reach back home or the alert message is sent to the family member or the caretaker. The alert message is sent while the person is out of the fencing area to himself or to the care takers and the location of the person can be tracked. This app can also be modified for different users like person with disability, game like pub-G players etc. for the situations where the device sense that the person is in a danger zone or out of the geo-fencing.&nbsp;<br>]]></description> </item><item><title><![CDATA[Neurological Examination]]></title><link>https://www.benthamscience.comchapter/20987</link><description><![CDATA[A neurological exam, also called a neuro exam, is an evaluation of a person's nervous system that can be done in the physcians. It may be done with instruments, such as lights and reflex hammers. It usually does not cause any pain to the patient. The nervous system consists of the brain, the spinal cord, and the nerves from these areas. There are many aspects of this exam, including an assessment of motor and sensory skills, balance and coordination, mental status (the patient's level of awareness and interaction with the environment), reflexes, and functioning of the nerves. The extent of the exam depends on many factors, including the initial problem that the patient is experiencing, the age of the patient, and the condition of the patient.&nbsp;<br>]]></description> </item><item><title><![CDATA[The Place of Mature Drugs in COVID-19 Era]]></title><link>https://www.benthamscience.comchapter/20887</link><description><![CDATA[COVID-19 infection, caused by the SARS-CoV-2 virus, is associated with substantial morbidity and mortality. COVID-19 infection has three distinct phases: 1, early infection phase; 2, pulmonary phase; and 3, the hyperinflammatory phase. Despite a major focus on vaccines and new therapeutics, existing drugs sharing some known mechanistic with this virus, have also gained interest. The potential positioning of three mature innovative drugs, which could be of potential use in this pandemic environment, is discussed in this chapter: OM-85 and calcium dobesilate, and their salt form etamsylate, have revealed anti-viral and anti-inflammatory properties. OM-85, a bacterial extract originating from 21 pathogenic strains isolated from human lungs and indicated for the prevention of recurrent respiratory tract infections, stimulates both innate and adaptive immunity, resulting in non-specific loco-regional immune responses. It has shown anti-viral activity in a number of virus infection models, including influenza H1N1, rhinovirus, and more recently, coronaviruses. It has also shown some immunoregulatory properties. Accordingly, there is a rationale for further investigations on OM-85 to be used as prophylaxis for other respiratory infections and potentially in long-COVID. For calcium dobesilate, currently indicated for the treatment of microvascular diseases while preserving microvascular integrity via antioxidant and anti-inflammatory properties, there are cumulating data that could promote its potential use for the treatment during phase 2 to protect the vascular endothelium. Calcium dobesilate has anti-viral properties and was recently shown to interfere with the SARS-CoV-2 spike-protein binding to the ACE2 receptor. Accordingly, one could also postulate to use it during phase 1. Etamsylate, an antihaemorrhagic and antiangiogenic agent that improves platelet adhesiveness and restores capillary resistance, is indicated for the prevention and treatment of capillary haemorrhages. Considering its mechanism of action, etamsylate could be envisage for use as potential treatment during phase 3 for viral-induced complications. Importantly, none of these afore mentioned drugs are currently approved for the prevention or treatment of SARS-CoV-2 viral infection. Further, the conduction of well-designed clinical trials is warranted.<br>]]></description> </item><item><title><![CDATA[Machine Learning Techniques in Image Segmentation]]></title><link>https://www.benthamscience.comchapter/20825</link><description><![CDATA[Image is an important medium to express information easily. This paper deals with the content of image segmentation with machine learning. Segmentation is the process of extracting the information required from the image. Machine learning is the process that helps to classify to obtain good results. A number of algorithms are designed for the segmentation process. The algorithms are selected based on the application. Quality segmentation can be applied if the algorithm is fixed at the application level. Standalone methods can be used for real-time applications. Schematic segmentation is one of the best techniques used for segmenting images. Machine learning combines basic techniques to produce good results. The algorithms vary for different input images like MRI, CT Scans, Colour images, etc. Algorithms like k-mean clustering are mostly used in processing. Many problems occur in segmentation which can be removed by Bayesian architectures. The usage of machine learning improves accuracy and efficiency. Labeling, training and testing are some of the methods used in segmentation through machine learning.&nbsp;<br>]]></description> </item><item><title><![CDATA[Narrative Review of Mobile Technology: Evidence from Older Adults]]></title><link>https://www.benthamscience.comchapter/20799</link><description><![CDATA[In the 21st century, many developed countries have become aging societies. Although network speed, the improvement of smartphones, and 5G foster the growth of mobile technology, the employment of mobile technology exhibited a significant gap in the design and application of mobile technology that can be applied for older adults. This study analyses the design and implementation of mobile technologies to investigate novel mobile applications that support older adults in aged homes, by conducting a comprehensive discussion. As such, this study selects an expert narrative overview of a literature search from Google Scholar and archives. Analysis results reveal that designing new mobile apps, strengthening the interaction through VR technologies, and developing smartwatches for nursing homes. We need to consult older adults to ascertain if they are willing to use the technology. Mobile technology provides better support for older adults and monitors their health condition.&nbsp;<br>]]></description> </item><item><title><![CDATA[The Adoption of Mobile App for the Elderly in the 21st Century]]></title><link>https://www.benthamscience.comchapter/20798</link><description><![CDATA[In general, the elderly mainly face two kinds of problems, namely physical and mental. Such kinds of problems lead to the unfolded challenges for the elderly in the community. Also, it may increase the burden on the healthcare system in the long term. To this end, this chapter introduces the adoption of mobile apps for the elderly to increase the elderly social mobility and mitigate the overloaded public healthcare system in the future.<br>]]></description> </item><item><title><![CDATA[Dietary Patterns and Rheumatoid Arthritis]]></title><link>https://www.benthamscience.comchapter/20768</link><description><![CDATA[Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory disease that impairs patients' capacity to engage in everyday activities and deteriorates their quality of life. The disease develops in genetically vulnerable individuals via an autoimmune inflammatory process triggered by environmental stimuli. Diet and nutrition are potential environmental variables influencing the start and progression of the disease. Traditionally, nutrition and disease research has examined the relationships between individual nutrients, foods, or dietary groupings and risk factors with health outcomes. By examining food consumption in terms of dietary patterns, it is possible to gain complete knowledge of the combined effects of nutrients and foods on chronic illnesses. The Mediterranean, DASH, and vegetarian diets are preventive dietary patterns, whereas the Western diet stimulates RA activity.<br>]]></description> </item><item><title><![CDATA[The Traditional Immune Boosting Recipes]]></title><link>https://www.benthamscience.comchapter/20696</link><description><![CDATA[The immune system is amazingly complicated and vital for our survival. Several different systems and cell types of our body work effortlessly in ideal synchrony throughout the body to fight off pathogens and clear up dead cells. Our immune systems perform an implausible job by putting up a wall that can safeguard the disease-causing microorganisms. Our immune system requires equilibrium to function smoothly, so a person must eat and drink healthy balanced foods for getting energy and nutrients. The immunity related diseases may occur due to several factors such as seasonal change, environment factors, virus attacks, and simple stress. To combat these, we need to consume immunity-boosting foods and nutrients rich in antioxidants like Alium sativum, Alium cepa, Citrus limon, Withania somnifera,Moringa oleifera, Curcuma longa, etc., which can build up the immunity. The traditional system of medicine like Ayurveda and Siddha system of medicine quoted several traditional immune-boosting recipes like Maha- sudharshnachoornam, Talisadichoornam, Dhanavantam, Gulika-churnam, sitophaladichoornam, etc. Several times it is proven that lifestyle and dietary changes can result in a better immune system. A healthy lifestyle includes consuming foods which help in boosting immunity. In addition to keeping a balanced diet in our daily life, there is a necessity for traditional immunityboosting agents simultaneously. Traditional immunity-boosting agents are usually rich in vitamins, antioxidants, and other minerals and the requisite nutrients for maintaining equilibrium in the immune system. In this chapter, detailed information about Traditional immunity-boosting agents will be discussed.<br>]]></description> </item><item><title><![CDATA[Biological Functions of Elements of Main Groups]]></title><link>https://www.benthamscience.comchapter/20659</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Fast Foods: Chemical Composition and Implications for Health]]></title><link>https://www.benthamscience.comchapter/20639</link><description><![CDATA[With changing the scenarios of living style, professional work culture, and daily hectic routine, liberal and global thoughts are impacting our dietary patterns and normal food consumption. So the preference for foods is changing, and foods that can be ready in a shorter time, like “fast foods”, are gaining popularity among the masses, especially young generations. The fast food business has become one of the fastest-growing industries across the globe. This growing trend of fast food consumption has also brought several health-associated issues, like obesity and heart-related problems. Therefore, health-conscious people do like to know the chemical ingredients embedded in fast foods as well as their packaging and storage. For this purpose, the chemistry relating to quality aspects of fast foods, including nutritional, physiological, sensory, flavor, microbiological and packaging, is very important for healthy consumption of fast food for a healthy life. In this book chapter, we have made efforts to bring updated information related to fast food, its chemical composition and implications for human health.<br>]]></description> </item><item><title><![CDATA[Role of Dental Chairside Assistant in Minor Surgery]]></title><link>https://www.benthamscience.comchapter/20506</link><description><![CDATA[In order to become a good chairside assistant, it is important to understand the basic fundamentals of oral surgery. The dental chairside assistant helps to save time, improve communications and handle emergencies. He/she is crucial in care and sterilization of instruments. This chapter provides a framework for learning the basic skills of assisting in minor oral surgery procedures.<br>]]></description> </item><item><title><![CDATA[Breast Cancer Detection Using Machine Learning Concepts]]></title><link>https://www.benthamscience.comchapter/20404</link><description><![CDATA[Machine learning is applied in medical diagnosis to do early prediction of diseases, for increasing the possibility of recoverability around the globe. Cancer is a disease, which spreads quickly and would be difficult to control in advanced stages. The idea is to diagnose the disease at an early stage, so as to increase the chances of fast recovery. Breast cancer is common in women, and is a disease that causes the death of women in the age of fifty years or older. The purpose is to apply machine learning concepts to do early detection of disease. The system is fed with the images of all stages of cancer patients and the classification tools are used to train the system with the cases. This helps to predict the stage of cancer. After the prediction of the stage, the patient is prescribed with the medication or other appropriate treatment processes by the doctor. The right time diagnoses help to improve the prognosis and increase the chances of survival. The type of the tumour, size and its re-occurring nature need to be monitored from time to time to check it in control. The Data Mining algorithm in collaboration with Deep learning or Machine learning concepts can be used to design a system for early predictions. The proposal is to use the machine learning concepts to do performance comparison using different classifiers, such as Support Vector Machine (SVM), Decision Tree and K-Nearest Neighbour (KNN) on the Wisconsin Diagnostic Breast Cancer (WDBC) dataset [1]. The main aim of cancer detection is to classify tumours into malignant or benign, thus we use machine learning techniques to improve the accuracy of diagnosis. The main objective is to assess the efficiency, effectiveness and correctness of the algorithm using performance metrics like Accuracy, Precision, F1 score and Recall Experimentation is done using Jupyter Notebook.&nbsp;<br>]]></description> </item><item><title><![CDATA[Role of Artificial Intelligence in Healthcare Management]]></title><link>https://www.benthamscience.comchapter/20312</link><description><![CDATA[Artificial intelligence (AI) has recently become one of the most heavily debated themes in the technological world. AI is active in numerous fields and now it has lately entered the healthcare sector. In addition to biomarkers, the use of AI is increasing in a variety of applications such as genetic editing, disease prediction and diagnostics, drug development, personalized treatment, and so on. Accuracy in disease diagnostics is essential for effective and efficient treatment as well as patient safety. Artificial intelligence is a wide and varied field of data, analytics and continuously evolving insights that meet the needs of the healthcare sector as well as patients. The purpose of the many subsections in this book chapter is to shed light on how AI integrated with machine learning (ML) &amp; Deep-learning (DL) techniques operate in various disease diagnosis domains, medication discovery, medical visualization, digital health records, and electro-medical equipment.&nbsp;<br>]]></description> </item><item><title><![CDATA[Biosensors for Neurodegenerative Diseases]]></title><link>https://www.benthamscience.comchapter/20269</link><description><![CDATA[Since the conception of biosensor technology in biomedical research, this field is emerging as a promising and high-throughput tool for neuro-engineering and neurosciences research. It has been postulated that the accumulating property proteins are the basic cause of neurodegenerative diseases, such as Parkinson’s disease, Alzheimer’s disease and prion diseases. Thus, neurodegenerative diseases are also called “protein misfolding disorders”. Biosensors have a wide range of applications in biomedical research, including optical and electrochemical detection of biometal-protein interactions, detection of biomarkers, such as β-amyloids, apolipoprotein, and tau proteins, and microRNA in blood and cerebrospinal fluid in neurodegenerative diseases. These are composed of primary biological recognition elements that convert the chemical signal into the voltage or current that evaluates the physical signal by preparing a plot of sensor response against the analyte concentration. This chapter presents a bird’s eye view on various aspects of progress in biosensor development with special emphasis on their application, including metal-protein interactions studies, detection of neurotransmitters using aptamers and calixarenes, detection of biomarkers proteins, such as α-synuclein for Parkinson’s disease, apolipoprotein, tau and β-amyloid proteins for Alzheimer’s disease, and prion proteins. The chapter also summarizes the novel materials reported for improved biosensor performance. This chapter will be of high relevance to the biological scientists working in neuro-engineering and neurosciences research<br>]]></description> </item><item><title><![CDATA[Theranostics Micelles for Brain Tumor Diagnosis and Treatment]]></title><link>https://www.benthamscience.comchapter/20167</link><description><![CDATA[Brain cancer is considered one of the most vicious and devastating tumors owing to its poor prognosis and high mortality rate. Common strategies for treatment include surgery, radiation, and chemotherapy. Unfortunately, these are limited due to their invasive nature and the inherent difficulties of brain surgery, given there is a high possibility of tumor relapse. Further, radiation and chemotherapy have a non-selective harmful effect on normal tissues, accompanied by limited drug delivery due to the presence of various barriers, including the blood-brain barrier. For this reason, the theranostic approach was developed by incorporating one or more therapeutic and diagnostic agents in a single nanocarrier moiety which could be modulated at its surface with certain proteins, legend, surface markers, or a stimuli-responsive agent that is capable of selectively targeting the tumor site after passing through the blood-brain barrier. This new field will permit the early and precise detection of cancer tissue, facilitate the process of drug delivery and assist in monitoring treatment outcomes. Micelles are considered one of the most commonly used nanocarriers due to their high stability and loading capacity, along with efficient release controlling properties. This chapter will present brief information about brain anatomy and cancer, and will discuss the main strategies implemented in the diagnosis and treatment of brain cancers. Furthermore, it will introduce the theranostic micelle approach by highlighting micelles types and preparation techniques, as well as explain the different barriers and approaches to targeting.<br>]]></description> </item><item><title><![CDATA[Barriers to Targeted Drug Delivery Strategies in Brain]]></title><link>https://www.benthamscience.comchapter/20162</link><description><![CDATA[Brain tumor is considered to be the most detrimental disease found in humans. Amongst the various brain tumors, glioblastoma has emerged as a highly invasive malignant disease that has contributed to significant mortality worldwide. Despite surgical and drug innovations, most of the patients suffering from brain tumours have shown poor prognosis, with a median life span. The presence of the blood-brain barrier (BBB) acts as a protective layer outside the brain for most of the conventional, diagnostic and therapeutic agents, which in turn leads to poor diagnosis and less efficacy in most clinical subjects. In recent years, multifunctional nanotechnology systems have been employed to deliver theranostic agents to the brain, showing promising outcomes in the treatment of various forms of cancer. The present chapter provides comprehensive information on the most recent developments in BBB-crossing nanotechnology, with a slight focus on the thoughtful design of multifunctional nanoplatforms for effective BBB penetration, accurate tumor imaging, and substantial brain tumor inhibition. Besides, various physiological barriers and transportation mechanisms, different drug delivery systems for brain tumors are also highlighted. Furthermore, major advancements in brain tumor theranostics pertaining to employing different nanosystems such as liposomes, polymeric nanoparticles, bio-nano particles, and inorganic-nanoparticles for effective nano-drug delivery for theranostics in brain tumors have also been discussed.&nbsp;<br>]]></description> </item><item><title><![CDATA[Role of Functional Foods in the Amelioration of Alzheimer's and Related Diseases]]></title><link>https://www.benthamscience.comchapter/20142</link><description><![CDATA[Alzheimer's disease (AD) is a neurological illness that causes a person's memory to deteriorate over time, as well as facing difficulties speaking and performing daily tasks. Alzheimer's disease affects around 42 million people worldwide, and this number is expected to quadruple by 2030. A nutraceutical is a bioactive component of human nutrition that is ready to be employed for disease prevention or therapy. The market for nutraceuticals has risen in the recent decade as public awareness of these compounds has grown, as has their utility in the prevention and treatment of a variety of ailments. Antioxidant-rich diets have been found to protect humans from degenerative diseases, such as cancer, diabetes and cardiovascular disease. Plant foods, such as vegetables, fruits, grains, spices, and legumes, have been shown to play important roles in the prevention and treatment of a wide range of chronic diseases by altering many metabolic pathways. Bioactive agents are extra from the functional food and are nutritional elements found naturally in plants that have the potential to have a biological effect. Now, scientists and nutritionists say that the link between nutrition and disease is a relatively recent discovery. The importance of functional foods in the treatment of chronic and neurodegenerative disorders, with a focus on AD, will be highlighted in this chapter.<br>]]></description> </item><item><title><![CDATA[Chromenes and Nutraceuticals]]></title><link>https://www.benthamscience.comchapter/19916</link><description><![CDATA[Nutraceuticals have received tremendous interest in the treatment or prevention of multiple diseases in modern times. Chromenes (Benzopyran), phytochemicals that are polyphenolic secondary metabolites, are one of the privileged scaffolds that occur in various natural products as essential structural components and also have beneficial nutraceutical properties. Chromenes are more correctly referred to as ‘nutraceuticals' due to their variety of pharmacological activities in the mammalian body. A better understanding of their mechanisms and biological activities suggests their ability as therapeutic agents and also for predicting and monitoring food quality due to their significance in food organoleptic properties and human health. In this chapter, the discussion will be on the diverse therapeutic actions of chromenes as well as the probable mechanisms of action that are responsible for their therapeutic activity. The origins of these chromenes, their extraction from these sources, and their use as nutraceutical components in various food items will also be discussed. The pharmacological relevance of chromenes, which may be added to staple foods to create various nutraceutical products, will also be discussed. As shall be evident after reading this chapter, chromenes as pharmacological agents have a wide range of targets. As a result, medicinal chemistry and quantitative structure-activity relationships should be used to focus on their specific biological action when developing new congeners of chromenes to be used as drugs.&nbsp;<br>]]></description> </item><item><title><![CDATA[Sterols, Carotenoid and Polyprenols]]></title><link>https://www.benthamscience.comchapter/19857</link><description><![CDATA[Isoprenoid compounds are a family of compounds constructed with isoprene as the basic unit but with very different structures, including monoterpenes, diterpenes and polyterpenes. Isoprenoid compounds mainly include ergosterol, steroids, carotene, carotenoids, polyisoprene, and their structures range from relatively simple linear hydrocarbon chains to highly complex cyclic structures, in which the cyclic structure is cyclized by terpenoids. Enzymes, also known as terpene synthase catalyzed by them, are also called cyclic terpenes. Isoprenoids are widely distributed in archaea, bacteria, and eukaryotes, and a variety of isoprenoids are essential components of the biological mechanism of the organism. For example, in mammals, β-carotene (β-carotene) is the precursor substance of Vitamin A. β-carotene has the function of preventing oxidation reactions, and can inhibit and eliminate oxygen free radicals in the body, and has various effects such as slowing down aging and improving resistance. At the same time, carotenoids can be combined with protein. Astaxanthin and protein combine to form astaxanthin, which makes aquatic animals appear body color and has a certain protective effect. Therefore, ergosterol, steroids, carotene, carotenoids and polyisoprene, which are relatively large in terpenoids, are all important products with commercial value and have been widely used in food, medicine, and daily chemical products.<br>]]></description> </item><item><title><![CDATA[A Comprehensive Overview of Estrogen: Physiological and Pathological Insights]]></title><link>https://www.benthamscience.comchapter/19783</link><description><![CDATA[Estrogens (estrone, estriol, and estradiol) are a class of steroidal hormones produced by developing ovarian follicles. These hormones induce various cyclic events in the uterine endothelium and vaginal epithelium and make the female body competent for conception and ultimately for motherly care. While estrogen is primarily produced by ovaries from cholesterol, the non-reproductive tissues including the brain, liver, and heart also produce a considerable amount of it. Apart from its important role in controlling sexual behavior and reproductive function, estrogen also functions in the regulation of various physiological functions including reproduction, skin physiology, cardiovascular health, skeletal homeostasis, bone integrity, electrolyte balance, cognition, and behavior. These biological functions are regulated by diffusion through the plasma membrane in vitro signaling through specific binding to nuclear receptors such as estrogen receptors (ERα and ERβ) or binding to cell membrane receptors such as GPR30 and ER-X. The signaling mechanism can be genomic (change in gene expression) or non-genomic (activation of various signaling cascades). Disruption in estrogen functioning has a pivotal role in the pathogenesis of many diseases such as osteoporosis, insulin resistance, neurodegenerative disease, obesity, and endometriosis. Also, dysregulation in the levels of estrogen has been linked to the development of many cancers such as breast cancer, etc. This chapter aims to summarize the complete insight of estrogen by providing a clear understanding of its synthesis, receptor binding, signaling, regulation of physiological functions, and role in various diseases.<br>]]></description> </item><item><title><![CDATA[Terpenes, Terpenoids and Steroids: Properties, Biosynthesis and Functions]]></title><link>https://www.benthamscience.comchapter/19778</link><description><![CDATA[Terpenes belong to the largest class of secondary metabolites consisting of five carbon isoprene units which are assembled through innumerable patterns generating diverse structural motifs. Terpenes are linear or cyclic hydrocarbons, whereas terpenoids are oxygen-containing terpene analogues found in all living organisms. Steroids are a subclass of terpenoids that are biosynthesized from terpene precursors. Terpenes, terpenoids and steroids are all derived from five-carbon isoprene units assembled and arranged in different ways generating thousands of structurally varied molecules. Terpenes and terpenoids are widely explored as biomaterials and biofuels while steroids are used as drugs to increase protein synthesis in animals besides their anti-inflammatory, anticancer and other properties. In this chapter, we discuss the properties, functions and biosynthesis of terpenes and terpenoids in general and steroids in particular to better understand their functions and prospective applications.<br>]]></description> </item><item><title><![CDATA[Prevention of Reperfusion Injury in Acute Myocardial Infarction: A “flashback” Journey of Novel Strategies Based on the Potential Therapeutic Role of Antioxidants]]></title><link>https://www.benthamscience.comchapter/19773</link><description><![CDATA[It has been recognized that oxidative stress plays a key role in the development of cardiac alterations derived from events of ischemia followed by reperfusion, such as in the clinical setting of acute myocardial infarction of patients subjected to coronary angioplasty. During ischemia, due to the occlusion of a coronary branch, biochemical events responsible for anaerobic metabolism, ATP availability and impairment of cell ionic homeostasis are the major deleterious effects. Following the onset of reperfusión, a burst of reactive oxygen species occurs, thus accounting for increased tissue damage due to the endovascular intervention. This iatrogenic damage has not been adequately treated to date. Among the many pharmacological attempts, cardioprotection with antioxidants should be mentioned; however, the experimental studies have not been translated into successful clinical trials aimed to prevent this enhancement of cardiac damage, despite some beneficial effects have been reported in the clinical outcome of the patients. This chapter aimed to present the hypothesis that the combination of antioxidant effects should improve the cardioprotection of the patients subjected to coronary angioplasty following acute myocardial infarction. Therefore, we present an update of previous attempts at cardioprotection with an antioxidant alone and give the basis for the expected improved protection by using two or more antioxidant compounds exerting different mechanisms that could enhance the beneficial protective effect.<br>]]></description> </item><item><title><![CDATA[The Emerging Role of Microbiome in Cardiovascular Diseases]]></title><link>https://www.benthamscience.comchapter/19771</link><description><![CDATA[Cardiovascular disease (CVD) has become one of the leading causes of poor lifelong health and well-being. Meanwhile, the microbiome has emerged as one of the key determinants of human cardiometabolic homeostasis and the risk of CVD. While the clustering of the microbiome into phylum ratios or enterotypes has been correlated to specific disease phenotypes and population characteristics, the composition of a typical ‘healthy human microbiome’ is yet to be defined. Several population-based studies have shown an association between certain microbial species with CVD, although the inconsistencies have made the interpretation of such associations very difficult as it is not possible to pinpoint microbial populations associated with CVD. However, here we discuss current evidence on the role of the microbiome and its metabolites on the risk of CVD. We further explore current clinical studies investigating prebiotics and probiotics as potential therapeutic targets to modulate the microbiome for the benefit of the host to prevent cardiometabolic diseases. We highlight that further work to understand the role of specific species/sub-species, strains and polymorphisms within those strains, as well as microbial gene expression profiles and their respective metabolites is required. Coupled with high-resolution metagenomics and metabolomics as well as a unified approach in characterising common gut microbial communities based on global population observations, this would provide better indicators of disease phenotype and a better framework for a divergence to dysbiosis. The challenges that will need to be overcome in order to define a healthy microbiome and advance the clinical use of prebiotics and probiotics as well as faecal microbiota transplantation will also be discussed.<br>]]></description> </item><item><title><![CDATA[Natural Immunomodulators for Infections and Other Diseases]]></title><link>https://www.benthamscience.comchapter/19255</link><description><![CDATA[Infection is one of the most common occurring issues in an individual. Diseases caused by infections hamper the immune system of an individual. To modulate the immune system, immunomodulatory drugs work by either stimulating or suppressing the immune system. Several drugs like levamisole and azathioprine are available in the market today to overcome various infections. But an alternative is required to overcome the drug resistance and other side effects associated with these available drugs. To tackle these problems, many plant-based immunomodulators are being explored and have proven to be beneficial against these infections. This chapter focuses on the mechanism of action and application of natural immunomodulators like Curcumin, Resveratrol, and Genistein on various infections. The primary goal of this chapter is to understand the role of natural immunomodulators in the body for various infections and related disease conditions. With the help of findings, one can conclude that all-natural immunomodulators have areas that need attention, including their therapeutic risk-benefit ratio and their target binding affinity for various infections. However, further investigations into these drugs are necessary for a clear understanding to maximize their clinical applications&nbsp;<br>]]></description> </item><item><title><![CDATA[A Survey on Brain-Computer Interface and Related Applications]]></title><link>https://www.benthamscience.comchapter/19213</link><description><![CDATA[Brain Computer Interface (BCI) systems are able to communicate directly between the brain and computer using neural activity measurements without the involvement of muscle movements. For BCI systems to be widely used by people with severe disabilities, long-term studies of their real-world use are needed, along with effective and feasible dissemination models. In addition, the robustness of the BCI systems' performance should be improved, so they reach the same level of robustness as natural muscle-based health monitoring. In this chapter, we review the recent BCIrelated studies, followed by the most relevant applications. We also present the key issues and challenges which exist in regard to the BCI systems and also provide future directions.<br>]]></description> </item><item><title><![CDATA[Alzheimer’s Disease and Physical Activity, Will the Symptoms Improve?]]></title><link>https://www.benthamscience.comchapter/19181</link><description><![CDATA[Alzheimer’s disease is known to be the most common cause of dementia with increasing number of people suffering every year. In healthy adults, there are millions of neurons in the brain. Degeneration starts and extends in Alzheimer's disease many years before the initial symptoms show up. The neurons taking part in cognitive functions destroy gradually leading to functional disability and finally to death. β- amyloid plaques and tau protein are known as the most responsible causes of Alzheimer’s disease resulting in neurodegeneration. Inflammation, atrophy and dysfunction in glucose metabolism will follow. The three stages of the disease include mild, moderate and severe. The patient will have difficulty in cognitive functions, show changes in behavior and will need care for everyday needs, which increases by the disease progress. There are pharmacologic and non-pharmacologic approaches for treatment. The pharmacologic approaches comprise acetylcholinesterase (AChE) inhibitors such as donepezil or N-methyl-d-aspartate (NMDA) receptor blockers like memantine. None of them stops the disease but alleviate the symptoms. On the other hand, non-pharmacologic approaches are usually used to improve the patient’s quality of life or improve the behavioral aspects of the disease. Recently, involving physical activity as a non-pharmacologic method of treatment for Alzheimer’s disease has been the focus of many studies. This chapter will have a glance at the clinical trials that were conducted regarding the effect of physical exercise and its impact on Alzheimer’s disease.<br>]]></description> </item><item><title><![CDATA[Phytosome for Targeted Delivery of Natural Compounds: Improving Efficacy, Bioavailability, and Delivery across BBB for the Treatment of Alzheimer's Disease]]></title><link>https://www.benthamscience.comchapter/19180</link><description><![CDATA[Alzheimer’s disease (AD) is a progressive neurological disorder. Recent studies show that AD is the most common cause of dementia. There are several symptomatic treatments available to counterbalance the neurotransmitter disturbance. Currently, cholinesterase inhibitors are available for the treatment of mild to moderate AD. In addition to that, memantine (an N-methyl-D-aspartate receptor non-competitive antagonist) is also available for moderate to severe AD. Poor blood-brain barrier permeability is a limitation of existing drugs. These drugs may slow the disease progression, but there are chances of reoccurrence of the disease. Several medicinal plants such as Jasminum sambac, Rosmarinus officinalis, Eucalyptus globulus, Nigella sativa, and Acorus gramineus are reported to have neuroprotective effects. Salvia officinalis has cholinergic binding properties. Ginger root extract may prevent behavioral dysfunction in AD. Extensive research on these plants should be carried out. Drug delivery systems such as lipid nanoparticles, polymer nanoparticles, nanomicelles, nano-gels, liposomes, phytosomes, etc., could significantly improve the pharmacokinetics, stability, efficacy and reduce the side effects. Phytosomes have the advantage over other drug delivery systems to selectively target the drugs into the brain. In contrast to traditional approaches, polar phytoconstituents loaded phytosomes are more bioavailable on the site of brain tissue, as they can easily go for systemic circulation crossing the Blood-Brain Barrier (BBB). Phytosomes have a low hazard profile as toxicological outcomes are negligible and assure duration of action at a lowrisk profile due to upgraded absorption of the active constituents. In addition to this, the improved pharmacodynamic properties of phytosomes make them suitable for the treatment of neurological disorders.<br>]]></description> </item><item><title><![CDATA[Neuroprotective Activities of Cinnamic Acids and their Derivatives]]></title><link>https://www.benthamscience.comchapter/19179</link><description><![CDATA[&nbsp;Neurodegenerative disorders are considered major global health problems associated with nervous system dysfunction, progressive neuronal cell loss with aging, and several pathological and sporadic factors. Parkinson’s disease, Alzheimer’s disease, Prion disease, Huntington’s disease, and multiple sclerosis are the main neurodegenerative diseases that raise significant concern among health scientists. The etiology of different neurodegenerative diseases is different, and they majorly affect the nervous system, including the brain, spinal cord, and peripheral nervous system. Neurodegenerative diseases are linked with motor dysfunction, anxiety, memory loss, depression, cognitive impairments, etc. These diseases can be hereditary or caused by toxicity, metabolic disorders, or pathological changes in the brain. Therefore, interest has been growing in the development of different neuroprotective agents of natural origin that could work effectively against these diseases. In that aspect, phytochemicals have shown high potential with minimal side effects in various in vitro and in vivo studies. Cinnamic acids with phenylpropenoic moiety are abundant in many natural resources. These are available in many forms, such as ferulic acid, caffeic acid, etc. They also have a variety of pharmacological properties, including anti-inflammatory, anti-oxidant, anti-amyloid, and neuroprotective properties. This chapter summarizes the role of naturally occurring cinnamic acids and their derivatives to develop the mechanistic aspects of neuroprotective therapeutics in neurodegenerative diseases. Future challenges are also discussed to provide beneficial information and therapeutic strategies.<br>]]></description> </item><item><title><![CDATA[Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases]]></title><link>https://www.benthamscience.comchapter/19177</link><description><![CDATA[The rapid increase in the incidence of dementia has enormous socioeconomic impacts and costs for governmental health systems all over the world. Despite this, finding an effective treatment for the different types of neurodegenerative diseases (NDs) so far represents a challenge for science. The biggest obstacles related to NDs are their multifactorial complexity and the lack of knowledge of the different pathophysiological pathways involved in the development of each disorder. The latest advances in science, especially those related to the systems biology concepts, have given new insights for a better comprehension of such multifactorial networks related to the onset and progression of NDs, and how Medicinal Chemists could act in the search for novel disease-modifying drug candidates capable of addressing the multiple pathological factors involved in neurodegeneration. The multi-target directed ligands (MTDLs) concept has captivated and opened new windows for the creativity and rationality of researchers worldwide in seeking innovative drug candidates capable of modulating different molecular targets by a single multifunctional molecule. In fact, in the last two decades, thousands of research groups have dedicated their efforts to the use of molecular hybridization as the main tool for the rational design of novel molecular scaffolds capable of expressing multi-target biological activity. In this way, this chapter addresses the most recent pathophysiological hallmarks of the most highimpact NDs, represented by Alzheimer’s, Parkinson’s, Huntington’s diseases, and amyotrophic lateral sclerosis, as well as the state-of-art in the design of new MTDLs, inspired mostly by natural products with improved druggability properties.<br>]]></description> </item><item><title><![CDATA[Classification and Diagnosis of Alzheimer’s Disease using Magnetic Resonance Imaging]]></title><link>https://www.benthamscience.comchapter/19048</link><description><![CDATA[Different types of brain illnesses can affect many parts of the brain at the same time. Alzheimer's disease is a chronic illness characterized by brain cell deterioration, which results in memory loss. Amnesia and ambiguity are two of the most prevalent Alzheimer's disease symptoms, and both are caused by issues with cognitive reasoning. This paper proposes several feature extractions as well as Machine Learning (ML) algorithms for disease detection. The goal of this study is to detect Alzheimer's disease using magnetic resonance imaging (MRI) of the brain. The Alzheimer's disease dataset was obtained from the Kaggle website. Following that, the unprocessed MRI picture is subjected to several pre-processing procedures. Feature extraction is one of the most crucial stages in extracting important attributes from processed images. In this study, wavelet and texture-based methods are used to extract characteristics. Gray Level Co-occurrence Matrix (GLCM) is utilized for the texture approach, and HAAR is used for the wavelet method. The extracted data from both procedures are then fed into ML algorithms. The Support Vector Machine (SVM) and Linear Discriminant Analysis (LDA) are used in this investigation. The values of the confusion matrix are utilized to identify the best technique.&nbsp;<br>]]></description> </item><item><title><![CDATA[Feature Extraction and Diagnosis of Dementia using Magnetic Resonance Imaging]]></title><link>https://www.benthamscience.comchapter/19041</link><description><![CDATA[Dementia is a state of mind in which the sufferer tends to forget important data like memories, language, etc.. This is caused due to the brain cells that are damaged. The damaged brain cells and the intensity of the damage can be detected by using Magnetic Resonance Imaging. In this process, two extraction techniques, Gray Level Co-Occurrence Matrix (GLCM) and the Gray Level Run-Length matrix (GLRM), are used for the clear extraction of data from the image of the brain. Then the data obtained from the extraction techniques are further analyzed using four machine learning classifiers named Support Vector Machine (SVM), K-Nearest Neighbor (KNN), Random Forest (RF), and the combination of two classifiers (SVM+KNN). The results are further analyzed using a confusion matrix to find accuracy, precision, TPR/FPR - True and False Positive Rate, and TNR/FNR – True and False Negative Rate. The maximum accuracy of 93.53% is obtained using the GLRM Feature Extraction (FE) technique with the combination of the SVM and KNN algorithm.<br>]]></description> </item><item><title><![CDATA[Taurine and the Mitochondrion]]></title><link>https://www.benthamscience.comchapter/18973</link><description><![CDATA[Several studies have evaluated the subcellular compartmentalization of taurine (TAU) and its cellular and molecular mechanisms of action. Meanwhile, it has been found that TAU is largely uptaken by mitochondria. TAU could improve mitochondrial function by incorporating it into the basic mitochondrial structures and protein synthesis (e.g., mainly mitochondrial electron transport chain components). Several other mechanisms, including the enhancement of mitochondrial calcium sequestration, regulation of mitochondria-mediated reactive oxygen species (ROS) formation, prevention of mitochondria-mediated cell death, and mitochondrial pH buffering, are also involved in the mitochondrial function regulatory properties of TAU. Therefore, TAU has been used against a wide range of pathologies, including mitochondrial injury. In the current chapter, a review of the approved molecular mechanism for the effects of TAU on mitochondria is provided. Then, the applications of TAU on a wide range of complications linked with mitochondrial impairment are discussed. The data collected here could give a better insight into the application of TAU as a therapeutic agent against a wide range of human diseases.<br>]]></description> </item><item><title><![CDATA[Molar Incisor Hypoplasia (MIH)]]></title><link>https://www.benthamscience.comchapter/18941</link><description><![CDATA[Developmental defects of enamel a commonly encountered condition in both primary and permanent teeth enamel. Ameloblasts being highly specialized cells are highly sensitive to a host of environmental factors. As a result, a large number of factors can cause hypomineralization. Of the various hypoplastic and hypomineralization defects affecting the enamel, this chapter focuses on a distinct condition of hypomineralization involving mainly the molar and incisor teeth.&nbsp;<br>]]></description> </item><item><title><![CDATA[Assistive Technology for Home Comfort and Care]]></title><link>https://www.benthamscience.comchapter/18851</link><description><![CDATA[Every second, individuals with physical and cognitive disabilities struggle so much to do some actions that normal people easily do within seconds. Assistive Technologies (AT) are those modules or sets of arrangements that aim to make life easy for disabled people, by stopping blockage and improving their mental and physical power. They improve their working capability, confidence, standard of living, and optimism. In modern times, Artificial Intelligence (AI) and technologies are developing rapidly, and new machines, motors, and mostly electronic devices powered by powerful batteries are being built every second. These are making it possible for disabled people to become self-dependent. Today, Assistive technology devices are efficient and suitable for disabled people. This chapter aims to provide in-depth knowledge about various types of disabilities, how disabled people face different problems and challenges, and how they can select and use assistive devices and mobile apps to live independently and comfortably.<br>]]></description> </item><item><title><![CDATA[Overview, Category and Ontology of Assistive Devices]]></title><link>https://www.benthamscience.comchapter/18848</link><description><![CDATA[The majority of physically challenged and elderly people demand a lot of care when it comes to assistive technologies that can provide tailored services to their needs. The primary concern of advancement in Assistive technology is to address a wide variety of disabilities and intellectual impairments for societal benefits by reducing welfare costs and allowing for an efficient workforce. To better respond to changes brought on by modernity, it is necessary to understand how assistive technology interacts in that group. The broad range of assistive devices in the continuum of assistive technology can help people with various impairments. Based on the underlying technology, the Categorization of assistive devices has important implications for clinical usage when examined through the perspective of social phenomenon. In the realm of Assistive Technology, a consistent focus on the relationship between the individual and the supported activity within certain contexts is essential. Assistive technology can be viewed from the perspective of various performance areas. The Ontology-based Assistive Devices that are among the finest within common, everyday contexts for more relevant applications are interesting. This chapter explores all those essential elementary and general considerations of assistive devices that form the bases of Assistive technology and brings out the categories of assistive devices and the various application domains where assistive devices can be served as a derivative of a particular ontology. The chapter focuses on the various performance areas by addressing the issues associated with Assistive technology Practice.<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/18847</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/18785</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Neuroprotective Effect of Natural Products in Attenuation of Aging-associated Neurodegeneration]]></title><link>https://www.benthamscience.comchapter/18784</link><description><![CDATA[Age-associated neurodegenerative disorders are a growing cause of mortality and morbidity in the elderly population globally. The patients suffering from neurodegenerative disorders pose medical, economic, and social issues. The agingassociated neurodegenerative disorders, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), have different clinical and neuropathological signatures, but they share a pattern of neurodegeneration in anatomical and functionally related regions. Natural products offer great potential in the prevention and therapy of neurodegenerative diseases. Plant-derived products protect neurons by targeting oxidative stress, mitochondrial dysfunction, neurotrophic factor deficit, and abnormal protein accumulation. The current chapter discusses the neuroprotective effect of natural products in the prevention of aging-associated neurodegenerative disorders.<br>]]></description> </item><item><title><![CDATA[Natural Herbs Polishing Memory: Neuroprotection against Alzheimer's Disease]]></title><link>https://www.benthamscience.comchapter/18783</link><description><![CDATA[Alzheimer's Disease (AD) is an irreversible and progressive neurodegenerative disorder that directly deteriorates the memory and cognitive function of the human brain in such a way that a person finds difficulties in dealing with daily life tasks. It is characterized by irregular neurofibrillary tangles (NFTs), intraneuronal accumulation, and the development of senile plaque (SP) consisting of abnormal polypeptide accumulation called βA4 amyloid. The pathophysiology can be collectively explained by five major hypotheses that are amyloid β (A β) hypothesis, the hyperphosporelated tau hypothesis, chronic inflammation, the cholinergic hypothesis, and the metal ion hypothesis. WHO estimated that a total of 40 million people worldwide are tested for the ill effects of dementia, and this is predicted to be twice as high as 114 million by around 2050. Currently, FDA-approved treatments for Alzheimer’s involve Donepezil, Rivastigmine, Galantamine, and Memantine that do not act specifically against Alzheimer's pathology and are also associated with loss of appetite, increased frequency of bowel movements, mental confusion, and dizziness as their side effects promote the approach to disease-modifying drugs. Nowadays, treatment with herbal medicines is a powerful alternative worldwide due to their high safety of margin against the side effects of allopathic drugs. Herbs are not restricted to a specific activity; they are generally enclosed with lignans, flavonoids, tannins, triterpenes, sterols, and alkaloids with wide pharmacological activities, such as antiinflammatory, anti-amyloidogenic, anti-cholinesterase, and anti-oxidant effects. Many herbal plants of India, such as Glycyrrhiza glabra, Acorus calamus, Convolvulus pluricaulis, Centella asiatica, Sesbania grandiflora, etc., have already proved their efficacies in treating dementia in various scientific studies.<br>]]></description> </item><item><title><![CDATA[Neuroprotective Effects of Berberine in Neurodegenerative and Neuropsychiatric Disorders]]></title><link>https://www.benthamscience.comchapter/18780</link><description><![CDATA[Berberine is an isoquinoline alkaloid obtained naturally from the roots, rhizomes, and bark of various plant species, such as Berberis, Phellodendron, etc. It is an integral part of various medical systems, such as Ayurveda, Chinese traditional medicine, and Yunani medicine. It possesses various properties, such as anti-diabetic and anti-obesity properties, controls lipid profile, and is a strong antioxidant that helps in protecting against oxidative stress. It acts on multiple pathways throughout the brain and periphery to exert a wide variety of effects that can be beneficial for human use. Berberine is effective in protecting against neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and ischemia, and it also protects against neuropsychiatric disorders, such as schizophrenia, mania, anxiety, and depression. It is a potent PI3K/Akt pathway activator, decreases proinflammatory cytokine production, reduces glutamate excitotoxicity, triggers the synthesis of neurotrophic factors, increases levels of biogenic monoamines, such as serotonin, dopamine, and norepinephrine, and shows anxiolytic effects by modulating GABA levels. In this chapter, we discuss how berberine mediates these effects, modulates which pathways in the brain and body, and how does it provide a wide array of responses.<br>]]></description> </item><item><title><![CDATA[Tinospora cordifolia in Neurodegeneration: A Strong Antioxidant and Anti-inflammatory Phytotherapeutic Drug Candidate]]></title><link>https://www.benthamscience.comchapter/18775</link><description><![CDATA[Tinospora cordifolia is a Rasayana herb of Ayurveda, commonly known as “Heavenly Elixir” or “Amrita”, and one of the most exploited herbs in herbal medicines. T. cordifolia is well reported for its various pharmacological properties, such as anti-diabetic, anti-inflammatory, antipyretic, immunomodulatory, anti-cancer, cardioprotective, neuroprotective, and hepatoprotective activities. The prevalence of neurodegenerative diseases and other neurologic disorders is increasing worldwide. Oxidative stress and neuroinflammation are among the major pathologic mechanisms underlying neurodegenerative diseases. This chapter discusses the pieces of scientific evidence of the beneficial effects of T. cordifolia in various brain-related ailments. Various research groups have demonstrated the ability of T. cordifolia and its extracts to normalize oxidative stress and suppress the inflammatory response against various causative agents, and thus suggested that T. cordifolia has the potential to be a neurotherapeutic drug candidate in the future.<br>]]></description> </item><item><title><![CDATA[Neuroprotective Role of Medicinal Plants from North Eastern Region of India]]></title><link>https://www.benthamscience.comchapter/18774</link><description><![CDATA[The term neurodegenerative disease means the loss of neuronal cells in the brain, including Alzheimer's disease, Parkinson's disease, Multiple sclerosis, and Huntington's disease. It is one of the most common types of disease associated with elevated rates of mortality and morbidity worldwide. At the same time, modern allopathic medicines have a large number of synthetic chemicals for the symptomatic treatment and control of these diseases. These drugs have failed miserably due to clinical insufficiency and debilitating adverse effects. In the past decade, natural ingredients have gained notable interest in the prevention and treatment of neurodegeneration due to their powerful anti-inflammatory and anti-oxidant properties with minimal side effects. However, there is also an issue of safety and effectiveness due to the absence of an ample amount of research findings. The most common cellular mechanism for every neurodegenerative disorder is neuroinflammation and oxidative stress. Several preclinical and clinical studies conducted across the world have demonstrated that different bioactive compounds of herbal origin can potentially arrest these processes to prevent or treat neurodegeneration and can be developed into promising pharmaceutical formulations. This article discusses and analyses the various herbal compounds, such as Allium sativum, Camella sinensis, Centella asiatica, Coriandrum sativum, Crocus sativus, Glycyrrhiza glabra, and Morus alba used for phytotherapy of neurodegenerative diseases by combining recent in vitro and in vivo models.<br>]]></description> </item><item><title><![CDATA[Delineating the Neuroinflammatory Crosstalk in Neurodegeneration and Probing the Near Future Therapeutics]]></title><link>https://www.benthamscience.comchapter/18771</link><description><![CDATA[Neurodegenerative disorders are threatening mankind with significant health and economic burden. Neurodegeneration involves the deterioration of neurons in the central nervous system (CNS), resulting in decreased neuronal survival. Therefore, it is of utmost requirement to develop a promising pharmacological strategy to minimize or prevent the progression of the underlying disease pathogenesis. In neurodegenerative disease conditions, neurons and glial cells present in the specific brain regions are damaged and depraved, resulting in specified disease symptoms in the patients. Neuroinflammation plays a major role in the degeneration of neuronal cells by regulating the expression of interleukin-1 beta (IL-1β), IL-6, IL-8, IL-33, tumor necrosis factor-alpha (TNF-α), chemokines Cxcl3 (C-C motif) ligand 2 (CCL2), CXCL5, granulocyte-macrophage colony-stimulating factor (GM-CSF), glia maturation factor (GMF), substance P, reactive oxygen species (ROS), reactive nitrogen species (RNS), impaired tuning of immune cells and nuclear factor kappa-B (NF-κB). Considering this, it is very important to understand the in-depth role of neuroinflammation in the initiation and progression of various neurodegenerative diseases, including Alzheimer's Disease (AD), Parkinson's Disease (PD), Huntington's Disease (HD), as well as Multiple Sclerosis (MS). Recent shreds of evidence have suggested that using exogenous ligands to approach various biological molecules or cellular functioning that modulates the neuroinflammation, such as microglia response, P2X7 receptors, TLR receptors, oxidative stress, PPARγ, NF-κB signaling pathway, NLRP3 inflammasome, caspase-1 signaling pathway, and mitochondrial dysfunction, helps to combat neurodegeneration in a variety of diseases. Thus, targeting the neuroinflammatory drive could provide a beacon for the management of neurodegenerative diseases. Here, we have attempted to provide comprehensive literature suggesting the role of neuroinflammation in neurodegeneration and its implication in the development of near-future neurotherapeutics.<br>]]></description> </item><item><title><![CDATA[Sleep Medicine in Hong Kong – Development, Knowledge Gaps and Future Challenges]]></title><link>https://www.benthamscience.comchapter/18691</link><description><![CDATA[The development of sleep medicine in Hong Kong has often been driven by clinical needs. The 1980s saw a surge of interest in sleep apnoea and brought multiple specialties together to study the diagnosis and management of sleep-related breathing disorders. Sleep and mood disorders often go hand in hand. With circadian disruption and sleep deprivation impacting the general population, including our paediatric age groups, the lack of quality sleep is a public health concern. Unfortunately, training in sleep medicine has been fragmented from undergraduate curricula to specialty training requirements. Sleep service standardisation is just beginning, although progress has been slow. Due to the lack of a specialty board, the Hong Kong Society of Sleep Medicine is providing a platform for interdisciplinary collaboration especially in training and education for both healthcare professionals and the general public, while the university-affiliated departments will provide the lead for multi-disciplinary research.<br>]]></description> </item><item><title><![CDATA[Nanomedicine Technology Trends in Pharmacology]]></title><link>https://www.benthamscience.comchapter/18649</link><description><![CDATA[Nanotechnology deals with materials that are 1–100 nm in size. Nanomaterials are prepared in different ways such as physical, chemical, and biological methods. They exhibit fascinating features that allow them to perform numerous physiological tasks. They have higher surface area to volume ratios and show typical nanoscale quantum confinement characteristics. They play a critical role in biomedical research. They're quite versatile and used in a variety of medical applications. The demand for nanomedicine drugs with improved performance and reduced toxicity has been steadily increasing in recent years. Nanomedicine is the new area of nanoscience and nanotechnology. Pharmaceutical nanosystems are classified, synthesized, and characterized using procedures based on their size, shape, and functionality. This book chapter focuses on recent trends of nanomedicine technology in pharmacology, particularly on the application of nanomaterials in medicine. Antibacterial characteristics, multicolor medical imaging, disease diagnostics, medication administration, vaccines and biomolecules (peptides, proteins, and genes), therapies, cancer treatment, tissue engineering, and clinical aspects are discussed. Advancements in nanomedicine technology will not only aid in the early diagnosis of infectious and viral disorders, but also in the treatment of infections such as Alzheimer's disease, tuberculosis, and Parkinson's disease. The benefits and constraints of commercializing nanomedicine technology products for pharmacology applications, as well as the hazards and obstacles in developing nanomaterials for medical research are highlighted in this chapter.<br>]]></description> </item><item><title><![CDATA[Smart Wearable Sensor Design Techniques For Mobile Health Care Solutions]]></title><link>https://www.benthamscience.comchapter/18638</link><description><![CDATA[In this chapter, we discuss the technological developments that have led to the clinical utility of smart wearable body sensors. Smart wearable sensors can enhance the physician-patient relationship, promote remote monitoring techniques, and their impact on healthcare management and expenditure. We explore how continuous health status monitoring can be achieved with the help of wireless sensors, wireless communication, microprocessors, and data processing algorithms. Furthermore, we also discuss the impact of using wearable sensor systems by infants and aged persons to alert parents/caretakers/clinicians. We also explore integrating smart wearable sensors and IoT to enhance the automatic monitoring and alerting systems for health care improvement.<br>]]></description> </item><item><title><![CDATA[Subject Index]]></title><link>https://www.benthamscience.comchapter/18609</link><description><![CDATA[]]></description> </item><item><title><![CDATA[Health Promoting Properties of Grewia asiatica and Grewia tenax Berries: A Potential Role in Cancer, Diabetes, and Liver Diseases Prevention]]></title><link>https://www.benthamscience.comchapter/18602</link><description><![CDATA[Himalayan regions are a great source of berries. Berries are well-known for their nutritional benefits, which include low calorie, high vitamin, and fiber content. For millennia, indigenous cultures have used edible berries for food and medical purposes. In Ayurveda, the consumption of fresh berries is recommended for their health benefits and the prevention of non-communicable chronic diseases. They are also considered a part of the ‘Satvik Foods’ that promote health and wellbeing, inner happiness, stress reduction, and memory enhancement. Currently, berries are promoted as nutraceuticals for the prevention of cancer, diabetes mellitus, obesity, liver abnormalities, cardiovascular disorders, and neurodegenerative diseases. Berries of plants belonging to the genus Grewia are traditionally used for nutrition as well as medicinal purposes, but these are less explored. In particular, the berries of Grewia asiatica and Grewia tenax species have been scantily explored for their medicinal properties and bioactive constituents despite their plenty of uses in folklore medicines. The focus of this chapter is to highlight the traditional uses, phytochemical composition, and pharmacological potential of G. asiatica and G. tenax berries along with mechanistic pathways of their action. Hopefully, such an attempt would attract the attention of basic researchers, the nutraceutical industry, natural therapists, Ayurveda practitioners, and the public at large.<br>]]></description> </item><item><title><![CDATA[Himalayan Herbs: A Promising Medication Source for Neurodegenerative Diseases]]></title><link>https://www.benthamscience.comchapter/18600</link><description><![CDATA[The Himalayas have been known for their plant diversity, as they are rich in nearly 8000 vascular plant species, which include approximately 1748 plants containing medicinal properties. Ayurveda, a branch of traditional medication focuses on substances of natural origin like plants, their parts, minerals, and animal parts either alone or in combination. With the advancement in Science and Technology, there has been an increase in the understanding of molecular mechanisms behind the origin of diseases. Recently, the roles of several bioactive molecules present in natural sources in blocking or treating diseases have also become increasingly clear. Since the Himalayas are rich herbal treasures; therefore the plant diversity, as well as their medicinal properties have been widely explored.<br><br>Progressive loss of nerve cells/neurons in terms of structure and function is termed neurodegeneration. Selective loss of neurons leads to nervous disorders referred to as Neurodegenerative disorders/diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, etc., are some of the major health issues suffered by individuals in the current situation. Plant-derived bioactive molecules or phytomedicines have been in practice for many years and have been found to be effective in managing/treating these disorders.<br><br>This chapter aims at highlighting some of the Himalayan herbs, which exhibit a promising role in managing neurodegenerative diseases. For example, Acorus calamus is well known for its brain rejuvenating ability. It has been found that A. calamus possesses neuroprotective activity against stroke. Asparagus racemosus, known for its anti-aging activity, has been observed to protect the brain from oxidative damage, thereby preventing neurodegenerative diseases. Calotropis procera is ethnomedicinally used to treat mental disorders. Sida cordifolia, another perennial shrub found in the Himalayan region used for treating many ailments related to the respiratory system is also used for treating patients suffering from Parkinson’s disease. There are many more plants found in the Himalayan region, which have the potential for treating brainrelated disorders.<br><br>The rising cases of neurodegenerative disorders need a better understanding of plants rich in neuroprotective phytochemicals. Plants are one of the promising medication sources with the least side effects, which will help in providing an ethnopharmacological aspect and managing/treating neurodegenerative disorders. <br>]]></description> </item></channel></rss>